Industries > Pharma > 3D Bioprinting Market Report to 2031
3D Bioprinting Market Report to 2031
Forecasts by By Component (3D Bioprinters (Microextrusion bioprinting, Inkjet 3D Bioprinting, Laser-assisted Bioprinting, Magnetic 3D Bioprinting, and Other technologies), Bioinks (Natural Bioinks, Hybrid Bio inks, and Synthetic Bioinks), By Application (Research Applications (Drug Research, Regenerative Medicine, and 3D Cell Culture), Clinical Application (Skin, Bone & Cartilage, Blood Vessels, and Other Clinical Applications), By Material (Living Cells, Hydrogels, Extracellular Matrices, and Other Biomaterials), By End User (Research Organization & Academic Institutes, Biopharmaceuticals Companies, and Hospital) PLUS COVID-19 Recovery Scenarios
3D Bioprinting Market – our new study reveals trends, R&D progress, and predicted revenues
Where is the 3D Bioprinting market heading? If you are involved in this sector you must read this newly updated report. Visiongain’s report shows you the potential revenue streams to 2031, assessing data, trends, opportunities, and business prospects there.
Discover how to stay ahead
Our 500+ page report provides 600+ tables and charts/graphs. Read on to discover the most lucrative areas in the industry and future market prospects. Our new study lets you assess forecasted sales at the overall world market and regional level. See financial results, trends, opportunities, and revenue predictions. Much opportunity remains in this growing 3D Bioprinting Market. See how to exploit opportunities.
Forecasts to 2031 and other analyses reveal the commercial prospects
• In addition to revenue forecasting to 2031, our new study provides you with recent results, growth rates, and market shares.
• You find original analyses, with business outlooks and developments.
• Discover qualitative analyses (including market dynamics, drivers, opportunities, restraints, and challenges), product profiles, and commercial developments.
Discover sales predictions for the world market and submarkets
3D Bioprinting Market: By Component
• 3D Bioprinters
o Microextrusion bioprinting
o Inkjet 3D Bioprinting
o Laser-assisted Bioprinting
o Magnetic 3D Bioprinting
o Other technologies *
• Bioinks
o Natural Bioinks
o Hybrid Bioinks
o Synthetic Bioinks
3D Bioprinting Market: By Application
• Research Applications
o Drug Research
o Regenerative Medicine
o 3D Cell Culture
• Clinical Application
o Skin
o Bone & Cartilage
o Blood Vessels
o Other Clinical Applications
3D Bioprinting Market: By Material
• Living Cells
• Hydrogels
• Extracellular Matrices
• Other Biomaterials
3D Bioprinting Market: By End User
• Research Organization & Academic Institutes
• Biopharmaceuticals Companies
• Hospital
In addition to the revenue predictions for the overall world market and segments, you will also find revenue forecasts for 5 regional and 20 leading national markets:
• North America
o U.S.
o Canada
• Europe
o Germany
o France
o United Kingdom
o Italy
o Spain
o Rest of Europe
• Asia Pacific
o China
o Japan
o India
o Australia
o South Korea
o Rest of Asia Pacific
• Latin America
o Brazil
o Mexico
o Argentina
o Rest of Latin America
• Middle East and Africa
o Turkey
o Saudi Arabia
o South Africa
o UAE
o Egypt
o Rest of Middle East and Africa
The report also includes profiles and for some of the leading companies in the 3D Bioprinting Market, with a focus on this segment of these companies’ operations.
Leading companies and the potential for market growth
Our work identifies which organizations hold the greatest potential. Discover their capabilities, progress, and commercial prospects, helping you stay ahead. Overall world revenue for 3D Bioprinting Market will surpass $xx million in 2021, our work calculates. We predict strong revenue growth through to 2031.
How the 3D Bioprinting Market report helps you
In summary, our 500+ page report provides you with the following knowledge:
• Revenue forecasts to 2031 for 3D Bioprinting Market, with forecasts for Application, Components, Material, and End User each forecasted at a global and regional level– discover the industry’s prospects, finding the most lucrative places for investments and revenues
• Revenue forecasts to 2031 for 5 regional and 16 key national markets – See forecasts for the 3D Bioprinting market in North America, Europe, Asia-Pacific, and Rest of the World. Also forecasted are the market in the US, Canada, Argentina, Brazil, Germany, France, UK, Italy, Spain, China, India, Japan, and Australia among other prominent economies.
• Prospects for established firms and those seeking to enter the market– including company profiles for 10 of the major companies involved in the 3D Bioprinting Market. Some of the companies profiled in this report include EnvisionTEC GmbH, Organovo Holdings Inc., Cyfuse Biomedical K.K., 3Dynamic Systems Ltd, Nano3D Biosciences, Inc., Aspect Biosystems Ltd., and BioBots.
To access the data contained in this document please email contactus@visiongain.com
Buy our report today 3D Bioprinting Market Report to 2031: Forecasts by By Component (3D Bioprinters (Microextrusion bioprinting, Inkjet 3D Bioprinting, Laser-assisted Bioprinting, Magnetic 3D Bioprinting, and Other technologies), Bioinks (Natural Bioinks, Hybrid Bio inks, and Synthetic Bioinks), By Application (Research Applications (Drug Research, Regenerative Medicine, and 3D Cell Culture), Clinical Application (Skin, Bone & Cartilage, Blood Vessels, and Other Clinical Applications), By Material (Living Cells, Hydrogels, Extracellular Matrices, and Other Biomaterials), By End User (Research Organization & Academic Institutes, Biopharmaceuticals Companies, and Hospital) PLUS COVID-19 Recovery Scenarios. Avoid missing out by staying informed – order our report now.
Visiongain is a trading partner with the US Federal Government
CCR Ref number: KD4R6
Do you have any custom requirements we can help you with? Any need for a specific country, geo region, market segment or specific company information? Contact us today, we can discuss your needs and see how we can help: sara.peerun@visiongain.com
1. Report Overview
1.1. Introduction
1.2. Why You Should Read This Report
1.3. Key Questions Answered by This Analytical Report
1.4. Who is This Report For?
1.5. Methodology
1.6. Frequently Asked Questions (FAQ)
1.7. Associated Visiongain Reports
1.8. About Visiongain
2. Introduction to the 3D Bioprinting Market
2.1. 3D Bioprinting Market Definition
2.2. Component Submarkets Definitions
2.3. Application Submarkets Definitions
2.4. Material Submarkets Definitions
2.5. End-User Submarkets Definitions
3. 3D Bioprinting Market Overview
3.1. Global 3D Bioprinting Market Size and Forecast by Region
3.2. Global 3D Bioprinting Market Share by Region
3.3. Market Dynamics
3.3.1. Market Drivers
3.3.1.1. Increasing Use of 3D Bioprinting in the Pharmaceutical and Cosmetology Industries
3.3.1.2. Rising Public and Private Funding to Support Bioprinting Research Activities
3.3.1.3. Technological Advancements in the 3D Bioprinting Industry
3.3.2. Market Restraints/Challenges
3.3.2.1. A dearth of Skilled Professionals
3.3.2.2. High Development & Production Costs
3.3.2.3. Lack of Regulatory Guidelines Governing 3D Bioprinting
3.3.2.4. Socio-ethical Concerns Related to the Use of 3D Bioprinted Products
3.3.2.5. High Cost of 3D Bioprinting
3.3.2.6. Process Control & Understanding
3.3.3. Opportunities
3.3.3.1. Rising Demand for Organ Transplants
3.3.3.2. Growing Awareness of 3D Bioprinting
3.3.3.3. Growing Demand for Regenerative Medicine & Stem Cell Research
3.3.4. Global 3D Bioprinting Market: Trends
3.3.4.1. Research Focuses on Developing High-End 3D Bioprinting Ink
3.3.5. SWOT Analysis
3.3.5.1. Strengths
3.3.5.2. Weaknesses
3.3.5.3. Opportunities
3.3.5.4. Threats
3.3.6. Porter’s Five Forces Analysis
3.3.6.1. Competitive Rivalry
3.3.6.2. Supplier Power
3.3.6.3. Buyer Power
3.3.6.4. Threat of Substitution
3.3.6.5. The threat of New Entry
4. Global 3D Bioprinting Market Analysis and Forecast 2021-2031, by Component (Pre COVID and V, U, W, and L COVID Recovery Scenarios)
4.1. Market Overview
4.1.1. 3D Bioprinters
4.1.1.1. Microextrusion bioprinting
4.1.1.2. Inkjet 3D Bioprinting
4.1.1.3. Laser-assisted Bioprinting
4.1.1.4. Magnetic 3D Bioprinting
4.1.1.5. Other technologies
4.1.2. Bioinks
4.1.2.1. Natural Bioinks
4.1.2.2. Hybrid Bioinks
4.1.2.3. Synthetic Bioinks
5. Global 3D Bioprinting Market Analysis and Forecast, 2021-2031 by Application (Pre COVID and V, U, W, and L COVID Recovery Scenarios)
5.1. Market Overview
5.1.1. Research Applications
5.1.1.1. Drug Research
5.1.1.2. Regenerative Medicine
5.1.1.3. 3D Cell Culture
5.1.2. Clinical Application
5.1.2.1. Skin
5.1.2.2. Bone & Cartilage
5.1.2.3. Blood Vessels
5.1.2.4. Other Clinical Applications
6. Global 3D Bioprinting Market Analysis and Forecast, 2021-2031 by Material (Pre COVID and V, U, W, and L COVID Recovery Scenarios)
6.1. Market Overview
6.1.1. Living Cells
6.1.2. Hydrogels
6.1.3. Extracellular Matrices
6.1.4. Other Biomaterials
7. Global 3D Bioprinting Market Analysis and Forecast, 2021-2031 by End User (Pre COVID and V, U, W, and L COVID Recovery Scenarios)
7.1. Market Overview
7.1.1. Research Organization & Academic Institutes
7.1.2. Biopharmaceuticals Companies
7.1.3. Hospital
8. North America 3D Bioprinting Market Analysis and Forecast, 2021-2031 Pre COVID and V, U, W, and L COVID Recovery Scenarios)
8.1. Market Overview
8.2. North America 3D Bioprinting Market Size and Forecast by Component
8.3. North America 3D Bioprinting Market Size and Forecast by Application
8.4. North America 3D Bioprinting Market Size and Forecast by Material
8.5. North America 3D Bioprinting Market Size and Forecast by End User
8.6. U.S. 3D Bioprinting Market
8.7. Canada 3D Bioprinting Market
9. Europe 3D Bioprinting Market Analysis and Forecast, 2021-2031 (Pre COVID and V, U, W, and L COVID Recovery Scenarios)
9.1. Market Overview
9.2. Europe 3D Bioprinting Market Size and Forecast by Component
9.3. Europe 3D Bioprinting Market Size and Forecast by Application
9.4. Europe 3D Bioprinting Market Size and Forecast by Material
9.5. Europe 3D Bioprinting Market Size and Forecast by End User
9.6. UK 3D Bioprinting Market
9.7. Germany 3D Bioprinting Market
9.8. France 3D Bioprinting Market
9.9. Rest of Europe 3D Bioprinting Market
10. Asia Pacific 3D Bioprinting Market Analysis and Forecast, 2021-2031 (Pre COVID and V, U, W, and L COVID Recovery Scenarios)
10.1. Market Overview
10.2. Asia Pacific 3D Bioprinting Market Size and Forecast by Component
10.3. Asia Pacific 3D Bioprinting Market Size and Forecast by Application
10.4. Asia Pacific 3D Bioprinting Market Size and Forecast by Material
10.5. Asia Pacific 3D Bioprinting Market Size and Forecast by End User
10.6. China 3D Bioprinting Market
10.7. India 3D Bioprinting Market
10.8. Japan 3D Bioprinting Market
10.9. Rest of Asia Pacific 3D Bioprinting Market
11. Latin America 3D Bioprinting Market Analysis and Forecast, 2021-2031 (Pre COVID and V, U, W, and L COVID Recovery Scenarios)
11.1. Market Overview
11.2. Latin America 3D Bioprinting Market Size and Forecast by Component
11.3. Latin America 3D Bioprinting Market Size and Forecast by Application
11.4. Latin America 3D Bioprinting Market Size and Forecast by Material
11.5. Latin America 3D Bioprinting Market Size and Forecast by End User
11.5.1. Brazil 3D Bioprinting Market
11.5.2. Mexico 3D Bioprinting Market
11.5.3. Rest of Latin America 3D Bioprinting Market
12. MEA 3D Bioprinting Market Analysis and Forecast, 2021-2031 (Pre COVID and V, U, W, and L COVID Recovery Scenarios)
12.1. Market Overview
12.2. MEA 3D Bioprinting Market Size and Forecast by Component
12.3. MEA 3D Bioprinting Market Size and Forecast by Application
12.4. MEA 3D Bioprinting Market Size and Forecast by Material
12.5. MEA 3D Bioprinting Market Size and Forecast by End User
12.6. GCC 3D Bioprinting Market
12.7. South Africa 3D Bioprinting Market
12.8. Rest of MEA 3D Bioprinting Market
13. Companies in the 3D Bioprinting Market
13.1. Organovo Holdings, Inc.
13.1.1. Company Snapshot
13.1.2. Company Overview
13.1.3. Financial Performance (2015-2019)
13.1.3.1. Net Revenue
13.1.3.2. Gross Profit
13.1.3.3. Geographical Revenue, 2019
13.1.4. Product Offerings
13.1.5. Recent Initiatives (2017-2019)
13.2. CELLINK
13.2.1. Company Snapshot
13.2.2. Company Overview
13.2.3. Financial Performance (2015-2019)
13.2.3.1. Net Revenue
13.2.3.2. Gross Profit
13.2.3.3. Geographical Revenue, 2019
13.2.4. Product Offerings
13.2.5. Recent Initiatives (2017-2019)
13.3. Allevi Inc.
13.3.1. Company Snapshot
13.3.2. Company Overview
13.3.3. Financial Performance (2015-2019)
13.3.3.1. Net Revenue
13.3.3.2. Gross Profit
13.3.3.3. Geographical Revenue, 2019
13.3.4. Product Offerings
13.3.5. Recent Initiatives (2017-2019)
13.4. Aspect Biosystems Ltd.
13.4.1. Company Snapshot
13.4.2. Company Overview
13.4.3. Financial Performance (2015-2019)
13.4.3.1. Net Revenue
13.4.3.2. Gross Profit
13.4.3.3. Geographical Revenue, 2019
13.4.4. Product Offerings
13.4.5. Recent Initiatives (2017-2019)
13.5. EnvisionTEC GmbH
13.5.1. Company Snapshot
13.5.2. Company Overview
13.5.3. Financial Performance (2015-2019)
13.5.3.1. Net Revenue
13.5.3.2. Gross Profit
13.5.3.3. Geographical Revenue, 2019
13.5.4. Product Offerings
13.5.5. Recent Initiatives (2017-2019)
13.6. Cyfuse Biomedical K.K.
13.6.1. Company Snapshot
13.6.2. Company Overview
13.6.3. Financial Performance (2015-2019)
13.6.3.1. Net Revenue
13.6.3.2. Gross Profit
13.6.3.3. Geographical Revenue, 2019
13.6.4. Product Offerings
13.6.5. Recent Initiatives (2017-2019)
13.7. Poietis
13.7.1. Company Snapshot
13.7.2. Company Overview
13.7.3. Financial Performance (2015-2019)
13.7.3.1. Net Revenue
13.7.3.2. Gross Profit
13.7.3.3. Geographical Revenue, 2019
13.7.4. Product Offerings
13.7.5. Recent Initiatives (2017-2019)
13.8. TeVido BioComponents
13.8.1. Company Snapshot
13.8.2. Company Overview
13.8.3. Financial Performance (2015-2019)
13.8.3.1. Net Revenue
13.8.3.2. Gross Profit
13.8.3.3. Geographical Revenue, 2019
13.8.4. Product Offerings
13.8.5. Recent Initiatives (2017-2019)
13.9. Nano3D Biosciences, Inc.
13.9.1. Company Snapshot
13.9.2. Company Overview
13.9.3. Financial Performance (2015-2019)
13.9.3.1. Net Revenue
13.9.3.2. Gross Profit
13.9.3.3. Geographical Revenue, 2019
13.9.4. Product Offerings
13.9.5. Recent Initiatives (2017-2019)
13.10. ROKIT Healthcare
13.10.1. Company Snapshot
13.10.2. Company Overview
13.10.3. Financial Performance (2015-2019)
13.10.3.1. Net Revenue
13.10.3.2. Gross Profit
13.10.3.3. Geographical Revenue, 2019
13.10.4. Product Offerings
13.10.5. Recent Initiatives (2017-2019)
13.11. Other Notable Players
14. Conclusion
15. Glossary
Associated Visiongain Reports
Visiongain Report Sales Order Form
Appendix A
About Visiongain
Appendix B
Visiongain report evaluation form
LIST OF TABLES
Table 1 3D Bioprinting Market Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Table 2 3D Bioprinting Market Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Table 3 3D Bioprinting Market Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Table 4 3D Bioprinting Market Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Table 5 3D Bioprinting Market Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Table 6 3D Bioprinting Market Drivers & Restraints 2020
Table 7 3D Bioprinting Submarket Forecast by Component 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 8 3D Bioprinting Submarket Forecast by Component 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 9 3D Bioprinting Submarket Forecast by Component 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 10 3D Bioprinting Submarket Forecast by Component 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 11 3D Bioprinting Submarket Forecast by Component 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 12 3D Bioprinters Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) before COVID)
Table 13 3D Bioprinters Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Table 14 3D Bioprinters Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Table 15 3D Bioprinters Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Table 16 3D Bioprinters Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Table 17 Bioinks Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Table 18 Bioinks Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Table 19 Bioinks Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Table 20 Bioinks Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Table 21 Bioinks Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Table 22 3D Bioprinting Submarket Forecast by Application 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 23 3D Bioprinting Submarket Forecast by Application 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 24 3D Bioprinting Submarket Forecast by Application 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 25 3D Bioprinting Submarket Forecast by Application 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 26 3D Bioprinting Submarket Forecast by Application 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 27 Research Applications Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Table 28 Research Applications Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Table 29 Research Applications Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Table 30 Research Applications Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Table 31 Research Applications Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Table 32 Clinical Application Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) Before COVID)
Table 33 Clinical Application Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Table 34 Clinical Application Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Table 35 Clinical Application Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Table 36 Clinical Application Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Table 37 3D Bioprinting Market Forecast by Material 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Table 38 3D Bioprinting Market Forecast by Material 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Table 39 3D Bioprinting Market Forecast by Material 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Table 40 3D Bioprinting Market Forecast by Material 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Table 41 3D Bioprinting Market Forecast by Material 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Table 42 Living Cells Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Table 43 Living Cells Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Table 44 Living Cells Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Table 45 Living Cells Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Table 46 Living Cells Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Table 47 Hydrogels Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Table 48 Hydrogels Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Table 49 Hydrogels Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Table 50 Hydrogels Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Table 51 Hydrogels Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Table 52 Extracellular Matrices Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Table 53 Extracellular Matrices Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Table 54 Extracellular Matrices Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Table 55 Extracellular Matrices Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Table 56 Extracellular Matrices Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Table 57 Other Biomaterials Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Table 58 Other Biomaterials Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Table 59 Other Biomaterials Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Table 60 Other Biomaterials Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Table 61 Other Biomaterials Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Table 62 3D Bioprinting Market Forecast by End User 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Table 63 3D Bioprinting Market Forecast by End User 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Table 64 3D Bioprinting Market Forecast by End User 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Table 65 3D Bioprinting Market Forecast by End User 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Table 66 3D Bioprinting Market Forecast by End User 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Table 67 Research Organization & Academic Institutes Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Table 68 Research Organization & Academic Institutes Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Table 69 Research Organization & Academic Institutes Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Table 70 Research Organization & Academic Institutes Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Table 71 Research Organization & Academic Institutes Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Table 72 Biopharmaceuticals Companies Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Table 73 Biopharmaceuticals Companies Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Table 74 Biopharmaceuticals Companies Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Table 75 Biopharmaceuticals Companies Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Table 76 Biopharmaceuticals Companies Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Table 77 Hospital Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Table 78 Hospital Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Table 79 Hospital Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Table 80 Hospital Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Table 81 Hospital Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Table 82 Regional 3D Bioprinting Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 83 Regional 3D Bioprinting Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 84 Regional 3D Bioprinting Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 85 Regional 3D Bioprinting Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 86 Regional 3D Bioprinting Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 87 North America 3D Bioprinting Market Forecast by Component 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 88 North America 3D Bioprinting Market Forecast by Component 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 89 North America 3D Bioprinting Market Forecast by Component 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 90 North America 3D Bioprinting Market Forecast by Component 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 91 North America 3D Bioprinting Market Forecast by Component 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 92 North America 3D Bioprinting Market Forecast by Application 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 93 North America 3D Bioprinting Market Forecast by Application 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 94 North America 3D Bioprinting Market Forecast by Application 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 95 North America 3D Bioprinting Market Forecast by Application 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 96 North America 3D Bioprinting Market Forecast by Application 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 97 North America 3D Bioprinting Market Forecast by Material 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 98 North America 3D Bioprinting Market Forecast by Material 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 99 North America 3D Bioprinting Market Forecast by Material 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 100 North America 3D Bioprinting Market Forecast by Material 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 101 North America 3D Bioprinting Market Forecast by Material 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 102 North America 3D Bioprinting Market Forecast by End User 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 103 North America 3D Bioprinting Market Forecast by End User 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 104 North America 3D Bioprinting Market Forecast by End User 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 105 North America 3D Bioprinting Market Forecast by End User 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 106 North America 3D Bioprinting Market Forecast by End User 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 107 North America 3D Bioprinting Market Forecast by Country 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 108 North America 3D Bioprinting Market Forecast by Country 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 109 North America 3D Bioprinting Market Forecast by Country 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 110 North America 3D Bioprinting Market Forecast by Country 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 111 North America 3D Bioprinting Market Forecast by Country 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 112 US 3D Bioprinting Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 113 US 3D Bioprinting Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 114 US 3D Bioprinting Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 115 US 3D Bioprinting Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 116 US 3D Bioprinting Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 117 Canada 3D Bioprinting Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 118 Canada 3D Bioprinting Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 119 Canada 3D Bioprinting Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 120 Canada 3D Bioprinting Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 121 Canada 3D Bioprinting Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 122 Europe 3D Bioprinting Market Forecast by Component 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 123 Europe 3D Bioprinting Market Forecast by Component 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 124 Europe 3D Bioprinting Market Forecast by Component 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 125 Europe 3D Bioprinting Market Forecast by Component 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 126 Europe 3D Bioprinting Market Forecast by Component 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 127 Europe 3D Bioprinting Market Forecast by Application 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 128 Europe 3D Bioprinting Market Forecast by Application 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 129 Europe 3D Bioprinting Market Forecast by Application 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 130 Europe 3D Bioprinting Market Forecast by Application 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 131 Europe 3D Bioprinting Market Forecast by Application 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 132 Europe 3D Bioprinting Market Forecast by Material 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 133 Europe 3D Bioprinting Market Forecast by Material 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 134 Europe 3D Bioprinting Market Forecast by Material 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 135 Europe 3D Bioprinting Market Forecast by Material 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 136 Europe 3D Bioprinting Market Forecast by Material 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 137 Europe 3D Bioprinting Market Forecast by End User 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 138 Europe 3D Bioprinting Market Forecast by End User 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 139 Europe 3D Bioprinting Market Forecast by End User 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 140 Europe 3D Bioprinting Market Forecast by End User 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 141 Europe 3D Bioprinting Market Forecast by End User 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 142 Europe 3D Bioprinting Market Forecast by Country 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 143 Europe 3D Bioprinting Market Forecast by Country 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 144 Europe 3D Bioprinting Market Forecast by Country 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 145 Europe 3D Bioprinting Market Forecast by Country 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 146 Europe 3D Bioprinting Market Forecast by Country 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 147 UK 3D Bioprinting Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 148 UK 3D Bioprinting Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 149 UK 3D Bioprinting Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 150 UK 3D Bioprinting Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 151 UK 3D Bioprinting Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 152 Germany 3D Bioprinting Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 153 Germany 3D Bioprinting Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 154 Germany 3D Bioprinting Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 155 Germany 3D Bioprinting Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 156 Germany 3D Bioprinting Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 157 France 3D Bioprinting Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 158 France 3D Bioprinting Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 159 France 3D Bioprinting Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 160 France 3D Bioprinting Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 161 France 3D Bioprinting Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 162 Rest of Europe 3D Bioprinting Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 163 Rest of Europe 3D Bioprinting Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 164 Rest of Europe 3D Bioprinting Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 165 Rest of Europe 3D Bioprinting Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 166 Rest of Europe 3D Bioprinting Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 167 Asia Pacific 3D Bioprinting Market Forecast by Component 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 168 Asia Pacific 3D Bioprinting Market Forecast by Component 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 169 Asia Pacific 3D Bioprinting Market Forecast by Component 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 170 Asia Pacific 3D Bioprinting Market Forecast by Component 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 171 Asia Pacific 3D Bioprinting Market Forecast by Component 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 172 Asia Pacific 3D Bioprinting Market Forecast by Application 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 173 Asia Pacific 3D Bioprinting Market Forecast by Application 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 174 Asia Pacific 3D Bioprinting Market Forecast by Application 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 175 Asia Pacific 3D Bioprinting Market Forecast by Application 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 176 Asia Pacific 3D Bioprinting Market Forecast by Application 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 177 Asia Pacific 3D Bioprinting Market Forecast by Material 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 178 Asia Pacific 3D Bioprinting Market Forecast by Material 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 179 Asia Pacific 3D Bioprinting Market Forecast by Material 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 180 Asia Pacific 3D Bioprinting Market Forecast by Material 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 181 Asia Pacific 3D Bioprinting Market Forecast by Material 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 182 Asia Pacific 3D Bioprinting Market Forecast by End User 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 183 Asia Pacific 3D Bioprinting Market Forecast by End User 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 184 Asia Pacific 3D Bioprinting Market Forecast by End User 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 185 Asia Pacific 3D Bioprinting Market Forecast by End User 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 186 Asia Pacific 3D Bioprinting Market Forecast by End User 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 187 Asia Pacific 3D Bioprinting Market Forecast by Country 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 188 Asia Pacific 3D Bioprinting Market Forecast by Country 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 189 Asia Pacific 3D Bioprinting Market Forecast by Country 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 190 Asia Pacific 3D Bioprinting Market Forecast by Country 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 191 Asia Pacific 3D Bioprinting Market Forecast by Country 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 192 China 3D Bioprinting Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 193 China 3D Bioprinting Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 194 China 3D Bioprinting Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 195 China 3D Bioprinting Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 196 China 3D Bioprinting Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 197 India 3D Bioprinting Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 198 India 3D Bioprinting Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 199 India 3D Bioprinting Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 200 India 3D Bioprinting Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 201 India 3D Bioprinting Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 202 Japan 3D Bioprinting Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 203 Japan 3D Bioprinting Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 204 Japan 3D Bioprinting Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 205 Japan 3D Bioprinting Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 206 Japan 3D Bioprinting Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 207 RoAPAC 3D Bioprinting Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 208 RoAPAC 3D Bioprinting Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 209 RoAPAC 3D Bioprinting Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 210 RoAPAC 3D Bioprinting Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 211 RoAPAC 3D Bioprinting Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 212 Middle East 3D Bioprinting Market Forecast by Component 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 213 Middle East 3D Bioprinting Market Forecast by Component 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 214 Middle East 3D Bioprinting Market Forecast by Component 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 215 Middle East 3D Bioprinting Market Forecast by Component 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 216 Middle East 3D Bioprinting Market Forecast by Component 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 217 Middle East 3D Bioprinting Market Forecast by Application 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 218 Middle East 3D Bioprinting Market Forecast by Application 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 219 Middle East 3D Bioprinting Market Forecast by Application 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 220 Middle East 3D Bioprinting Market Forecast by Application 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 221 Middle East 3D Bioprinting Market Forecast by Application 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 222 Middle East 3D Bioprinting Market Forecast by Material 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 223 Middle East 3D Bioprinting Market Forecast by Material 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 224 Middle East 3D Bioprinting Market Forecast by Material 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 225 Middle East 3D Bioprinting Market Forecast by Material 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 226 Middle East 3D Bioprinting Market Forecast by Material 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 227 Middle East 3D Bioprinting Market Forecast by End User 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 228 Middle East 3D Bioprinting Market Forecast by End User 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 229 Middle East 3D Bioprinting Market Forecast by End User 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 230 Middle East 3D Bioprinting Market Forecast by End User 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 231 Middle East 3D Bioprinting Market Forecast by End User 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 232 Latin America 3D Bioprinting Market Forecast by Component 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 233 Latin America 3D Bioprinting Market Forecast by Component 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 234 Latin America 3D Bioprinting Market Forecast by Component 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 235 Latin America 3D Bioprinting Market Forecast by Component 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 236 Latin America 3D Bioprinting Market Forecast by Component 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 237 Latin America 3D Bioprinting Market Forecast by Application 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 238 Latin America 3D Bioprinting Market Forecast by Application 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 239 Latin America 3D Bioprinting Market Forecast by Application 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 240 Latin America 3D Bioprinting Market Forecast by Application 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 241 Latin America 3D Bioprinting Market Forecast by Application 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 242 Latin America 3D Bioprinting Market Forecast by Material 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 243 Latin America 3D Bioprinting Market Forecast by Material 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 244 Latin America 3D Bioprinting Market Forecast by Material 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 245 Latin America 3D Bioprinting Market Forecast by Material 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 246 Latin America 3D Bioprinting Market Forecast by Material 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 247 Latin America 3D Bioprinting Market Forecast by End User 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 248 Latin America 3D Bioprinting Market Forecast by End User 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 249 Latin America 3D Bioprinting Market Forecast by End User 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 250 Latin America 3D Bioprinting Market Forecast by End User 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 251 Latin America 3D Bioprinting Market Forecast by End User 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 252 Africa 3D Bioprinting Market Forecast by Component 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 253 Africa 3D Bioprinting Market Forecast by Component 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 254 Africa 3D Bioprinting Market Forecast by Component 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 255 Africa 3D Bioprinting Market Forecast by Component 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 256 Africa 3D Bioprinting Market Forecast by Component 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 257 Africa 3D Bioprinting Market Forecast by Application 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 258 Africa 3D Bioprinting Market Forecast by Application 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 259 Africa 3D Bioprinting Market Forecast by Application 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 260 Africa 3D Bioprinting Market Forecast by Application 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 261 Africa 3D Bioprinting Market Forecast by Application 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 262 Africa 3D Bioprinting Market Forecast by Material 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 263 Africa 3D Bioprinting Market Forecast by Material 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 264 Africa 3D Bioprinting Market Forecast by Material 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 265 Africa 3D Bioprinting Market Forecast by Material 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 266 Africa 3D Bioprinting Market Forecast by Material 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 267 Africa 3D Bioprinting Market Forecast by End User 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 268 Africa 3D Bioprinting Market Forecast by End User 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 269 Africa 3D Bioprinting Market Forecast by End User 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 270 Africa 3D Bioprinting Market Forecast by End User 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 271 Africa 3D Bioprinting Market Forecast by End User 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 272 Leading 10 3D Bioprinting Companies (Ranking, Company, Latest Total Company Sales US$M*, HQ)
Table 273 Organovo Holdings, Inc. Profile 2019 (CEO, HQ, Founded, Website)
Table 274 Organovo Holdings, Inc. 3D Bioprinting Selected Recent Contracts 2019 (Date, Contract Type, Details)
Table 275 Organovo Holdings, Inc. 3D Bioprinting Product Offering (Segment, Product Offerings)
Table 276 CELLINK Profile 2019 (CEO, HQ, Founded, Website)
Table 277 CELLINK 3D Bioprinting Selected Recent Contracts 2019 (Date, Contract Type, Details)
Table 278 CELLINK 3D Bioprinting Product Offering (Segment, Product Offerings)
Table 279 Allevi Inc. Profile 2019 (CEO, HQ, Founded, Website)
Table 280 Allevi Inc. 3D Bioprinting Selected Recent Contracts 2017-2019 (Date, Contract Type, Details)
Table 281 Allevi Inc. 3D Bioprinting Product Offering (Segment, Product Offerings)
Table 282 Aspect Biosystems Ltd. Profile 2019 (CEO, HQ, Founded, Website)
Table 283 Aspect Biosystems Ltd. 3D Bioprinting Selected Recent Contracts 2015-2019 (Date, Contract Type, Details)
Table 284 Aspect Biosystems Ltd. 3D Bioprinting Product Offering (Segment, Product Offerings)
Table 285 EnvisionTEC GmbH Profile 2019 (CEO, HQ, Founded, Website)
Table 286 EnvisionTEC GmbH 3D Bioprinting Selected Recent Contracts 2015-2019 (Date, Contract Type, Details)
Table 287 EnvisionTEC 3D Bioprinting Product Offering (Segment, Product Offerings)
Table 288 Cyfuse Biomedical K.K. Profile 2019 (CEO, HQ, Founded, Website)
Table 289 Cyfuse Biomedical K.K. 3D Bioprinting Selected Recent Contracts 2015-2019 (Date, Contract Type, Details)
Table 290 Cyfuse Biomedical K.K. 3D Bioprinting Product Offering (Segment, Product Offerings)
Table 291 Poietis Profile 2019 (CEO, HQ, Founded, Website)
Table 292 Poietis 3D Bioprinting Selected Recent Contracts 2015-2019 (Date, Contract Type, Details)
Table 293 Poietis 3D Bioprinting Product Offering (Segment, Product Offerings)
Table 294 TeVido BioComponents Profile 2019 (CEO, HQ, Founded, Website)
Table 295 TeVido BioComponents 3D Bioprinting Selected Recent Contracts 2015-2019 (Date, Contract Type, Details)
Table 296 TeVido BioComponents 3D Bioprinting Product Offering (Segment, Product Offerings)
Table 297 Nano3D Biosciences, Inc. Profile 2019 (CEO, HQ, Founded, Website)
Table 298 Nano3D Biosciences, Inc. 3D Bioprinting Selected Recent Contracts 2015-2019 (Date, Contract Type, Details)
Table 299 Nano3D Biosciences, Inc. 3D Bioprinting Product Offering (Segment, Product Offerings)
Table 300 ROKIT Healthcare Profile 2019 (CEO, HQ, Founded, Website)
Table 301 ROKIT Healthcare 3D Bioprinting Selected Recent Contracts 2015-2019 (Date, Contract Type, Details)
Table 302 ROKIT Healthcare 3D Bioprinting Product Offering (Segment, Product Offerings)
Table 303 Other Companies Involved in the 3D Bioprinting Market 2020 (Company, Location)
LIST OF FIGURES
Figure 1 3D Bioprinting Market Component Overview
Figure 2 3D Bioprinting Market Application Overview
Figure 3 3D Bioprinting Market Material Overview
Figure 4 3D Bioprinting Market End User Overview
Figure 5 3D Bioprinting Market Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Figure 6 3D Bioprinting Market Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Figure 7 3D Bioprinting Market Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Figure 8 3D Bioprinting Market Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Figure 9 3D Bioprinting Market Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Figure 10 3D Bioprinting Submarket Forecast by Component 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 11 3D Bioprinting Submarket Forecast by Component 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 12 3D Bioprinting Submarket Forecast by Component 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 13 3D Bioprinting Submarket Forecast by Component 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 14 3D Bioprinting Submarket Forecast by Component 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 15 3D Bioprinters Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Figure 16 3D Bioprinters Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Figure 17 3D Bioprinters Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Figure 18 3D Bioprinters Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Figure 19 3D Bioprinters Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Figure 20 Bioinks Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Figure 21 Bioinks Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Figure 22 Bioinks Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Figure 23 Bioinks Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Figure 24 Bioinks Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Figure 25 3D Bioprinting Submarket Forecast by Application 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 26 3D Bioprinting Submarket Forecast by Application 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 27 3D Bioprinting Submarket Forecast by Application 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 28 3D Bioprinting Submarket Forecast by Application 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 29 3D Bioprinting Submarket Forecast by Application 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 30 Research Applications Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Figure 31 Research Applications Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Figure 32 Research Applications Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Figure 33 Research Applications Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Figure 34 Research Applications Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Figure 35 Clinical Application Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Figure 36 Clinical Application Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Figure 37 Clinical Application Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Figure 38 Clinical Application Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Figure 39 Clinical Application Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Figure 40 3D Bioprinting Market Forecast by Material 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Figure 41 3D Bioprinting Market Forecast by Material 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Figure 42 3D Bioprinting Market Forecast by Material 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Figure 43 3D Bioprinting Market Forecast by Material 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Figure 44 3D Bioprinting Market Forecast by Material 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Figure 45 Living Cells Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Figure 46 Living Cells Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Figure 47 Living Cells Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Figure 48 Living Cells Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Figure 49 Living Cells Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Figure 50 Hydrogels Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Figure 51 Hydrogels Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Figure 52 Hydrogels Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Figure 53 Hydrogels Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Figure 54 Hydrogels Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Figure 55 Extracellular Matrices Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Figure 56 Extracellular Matrices Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Figure 57 Extracellular Matrices Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Figure 58 Extracellular Matrices Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Figure 59 Extracellular Matrices Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Figure 60 Other Biomaterials Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Figure 61 Other Biomaterials Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Figure 62 Other Biomaterials Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Figure 63 Other Biomaterials Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Figure 64 Other Biomaterials Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Figure 65 3D Bioprinting Market Forecast by End User 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Figure 66 3D Bioprinting Market Forecast by End User 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Figure 67 3D Bioprinting Market Forecast by End User 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Figure 68 3D Bioprinting Market Forecast by End User 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Figure 69 3D Bioprinting Market Forecast by End User 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Figure 70 Research Organization & Academic Institutes Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Figure 71 Research Organization & Academic Institutes Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Figure 72 Research Organization & Academic Institutes Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Figure 73 Research Organization & Academic Institutes Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Figure 74 Research Organization & Academic Institutes Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Figure 75 Biopharmaceuticals Companies Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Figure 76 Biopharmaceuticals Companies Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Figure 77 Biopharmaceuticals Companies Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Figure 78 Biopharmaceuticals Companies Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Figure 79 Biopharmaceuticals Companies Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Figure 80 Hospital Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Figure 81 Hospital Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Figure 82 Hospital Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Figure 83 Hospital Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Figure 84 Hospital Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Figure 85 Regional 3D Bioprinting Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 86 Regional 3D Bioprinting Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 87 Regional 3D Bioprinting Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 88 Regional 3D Bioprinting Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 89 Regional 3D Bioprinting Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 90 North America 3D Bioprinting Market Forecast by Component 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 91 North America 3D Bioprinting Market Forecast by Component 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 92 North America 3D Bioprinting Market Forecast by Component 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 93 North America 3D Bioprinting Market Forecast by Component 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 94 North America 3D Bioprinting Market Forecast by Component 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 95 North America 3D Bioprinting Market Forecast by Application 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 96 North America 3D Bioprinting Market Forecast by Application 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 97 North America 3D Bioprinting Market Forecast by Application 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 98 North America 3D Bioprinting Market Forecast by Application 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 99 North America 3D Bioprinting Market Forecast by Application 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 100 North America 3D Bioprinting Market Forecast by Material 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 101 North America 3D Bioprinting Market Forecast by Material 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 102 North America 3D Bioprinting Market Forecast by Material 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 103 North America 3D Bioprinting Market Forecast by Material 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 104 North America 3D Bioprinting Market Forecast by Material 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 105 North America 3D Bioprinting Market Forecast by End User 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 106 North America 3D Bioprinting Market Forecast by End User 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 107 North America 3D Bioprinting Market Forecast by End User 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 108 North America 3D Bioprinting Market Forecast by End User 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 109 North America 3D Bioprinting Market Forecast by End User 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 110 North America 3D Bioprinting Market Forecast by Country 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 111 North America 3D Bioprinting Market Forecast by Country 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 112 North America 3D Bioprinting Market Forecast by Country 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 113 North America 3D Bioprinting Market Forecast by Country 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 114 North America 3D Bioprinting Market Forecast by Country 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 115 US 3D Bioprinting Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 116 US 3D Bioprinting Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 117 US 3D Bioprinting Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 118 US 3D Bioprinting Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 119 US 3D Bioprinting Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 120 Canada 3D Bioprinting Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 121 Canada 3D Bioprinting Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 122 Canada 3D Bioprinting Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 123 Canada 3D Bioprinting Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 124 Canada 3D Bioprinting Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 125 Europe 3D Bioprinting Market Forecast by Component 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 126 Europe 3D Bioprinting Market Forecast by Component 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 127 Europe 3D Bioprinting Market Forecast by Component 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 128 Europe 3D Bioprinting Market Forecast by Component 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 129 Europe 3D Bioprinting Market Forecast by Component 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 130 Europe 3D Bioprinting Market Forecast by Application 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 131 Europe 3D Bioprinting Market Forecast by Application 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 132 Europe 3D Bioprinting Market Forecast by Application 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 133 Europe 3D Bioprinting Market Forecast by Application 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 134 Europe 3D Bioprinting Market Forecast by Application 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 135 Europe 3D Bioprinting Market Forecast by Material 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 136 Europe 3D Bioprinting Market Forecast by Material 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 137 Europe 3D Bioprinting Market Forecast by Material 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 138 Europe 3D Bioprinting Market Forecast by Material 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 139 Europe 3D Bioprinting Market Forecast by Material 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 140 Europe 3D Bioprinting Market Forecast by End User 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 141 Europe 3D Bioprinting Market Forecast by End User 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 142 Europe 3D Bioprinting Market Forecast by End User 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 143 Europe 3D Bioprinting Market Forecast by End User 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 144 Europe 3D Bioprinting Market Forecast by End User 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 145 Europe 3D Bioprinting Market Forecast by Country 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 146 Europe 3D Bioprinting Market Forecast by Country 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 147 Europe 3D Bioprinting Market Forecast by Country 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 148 Europe 3D Bioprinting Market Forecast by Country 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 149 Europe 3D Bioprinting Market Forecast by Country 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 150 UK 3D Bioprinting Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 151 UK 3D Bioprinting Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 152 UK 3D Bioprinting Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 153 UK 3D Bioprinting Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 154 UK 3D Bioprinting Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 155 Germany 3D Bioprinting Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 156 Germany 3D Bioprinting Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 157 Germany 3D Bioprinting Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 158 Germany 3D Bioprinting Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 159 Germany 3D Bioprinting Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 160 France 3D Bioprinting Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 161 France 3D Bioprinting Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 162 France 3D Bioprinting Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 163 France 3D Bioprinting Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 164 France 3D Bioprinting Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 165 Rest of Europe 3D Bioprinting Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 166 Rest of Europe 3D Bioprinting Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 167 Rest of Europe 3D Bioprinting Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 168 Rest of Europe 3D Bioprinting Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 169 Rest of Europe 3D Bioprinting Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 170 Asia Pacific 3D Bioprinting Market Forecast by Component 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 171 Asia Pacific 3D Bioprinting Market Forecast by Component 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 172 Asia Pacific 3D Bioprinting Market Forecast by Component 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 173 Asia Pacific 3D Bioprinting Market Forecast by Component 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 174 Asia Pacific 3D Bioprinting Market Forecast by Component 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 175 Asia Pacific 3D Bioprinting Market Forecast by Application 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 176 Asia Pacific 3D Bioprinting Market Forecast by Application 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 177 Asia Pacific 3D Bioprinting Market Forecast by Application 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 178 Asia Pacific 3D Bioprinting Market Forecast by Application 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 179 Asia Pacific 3D Bioprinting Market Forecast by Application 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 180 Asia Pacific 3D Bioprinting Market Forecast by Material 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 181 Asia Pacific 3D Bioprinting Market Forecast by Material 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 182 Asia Pacific 3D Bioprinting Market Forecast by Material 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 183 Asia Pacific 3D Bioprinting Market Forecast by Material 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 184 Asia Pacific 3D Bioprinting Market Forecast by Material 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 185 Asia Pacific 3D Bioprinting Market Forecast by End User 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 186 Asia Pacific 3D Bioprinting Market Forecast by End User 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 187 Asia Pacific 3D Bioprinting Market Forecast by End User 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 188 Asia Pacific 3D Bioprinting Market Forecast by End User 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 189 Asia Pacific 3D Bioprinting Market Forecast by End User 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 190 Asia Pacific 3D Bioprinting Market Forecast by Country 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 191 Asia Pacific 3D Bioprinting Market Forecast by Country 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 192 Asia Pacific 3D Bioprinting Market Forecast by Country 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 193 Asia Pacific 3D Bioprinting Market Forecast by Country 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 194 Asia Pacific 3D Bioprinting Market Forecast by Country 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 195 China 3D Bioprinting Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 196 China 3D Bioprinting Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 197 China 3D Bioprinting Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 198 China 3D Bioprinting Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 199 China 3D Bioprinting Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 200 India 3D Bioprinting Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 201 India 3D Bioprinting Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 202 India 3D Bioprinting Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 203 India 3D Bioprinting Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 204 India 3D Bioprinting Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 205 Japan 3D Bioprinting Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 206 Japan 3D Bioprinting Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 207 Japan 3D Bioprinting Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 208 Japan 3D Bioprinting Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 209 Japan 3D Bioprinting Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 210 RoAPAC 3D Bioprinting Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 211 RoAPAC 3D Bioprinting Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 212 RoAPAC 3D Bioprinting Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 213 RoAPAC 3D Bioprinting Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 214 RoAPAC 3D Bioprinting Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 215 Middle East 3D Bioprinting Market Forecast by Component 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 216 Middle East 3D Bioprinting Market Forecast by Component 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 217 Middle East 3D Bioprinting Market Forecast by Component 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 218 Middle East 3D Bioprinting Market Forecast by Component 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 219 Middle East 3D Bioprinting Market Forecast by Component 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 220 Middle East 3D Bioprinting Market Forecast by Application 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 221 Middle East 3D Bioprinting Market Forecast by Application 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 222 Middle East 3D Bioprinting Market Forecast by Application 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 223 Middle East 3D Bioprinting Market Forecast by Application 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 224 Middle East 3D Bioprinting Market Forecast by Application 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 225 Middle East 3D Bioprinting Market Forecast by Material 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 226 Middle East 3D Bioprinting Market Forecast by Material 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 227 Middle East 3D Bioprinting Market Forecast by Material 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 228 Middle East 3D Bioprinting Market Forecast by Material 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 229 Middle East 3D Bioprinting Market Forecast by Material 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 230 Middle East 3D Bioprinting Market Forecast by End User 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 231 Middle East 3D Bioprinting Market Forecast by End User 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 232 Middle East 3D Bioprinting Market Forecast by End User 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 233 Middle East 3D Bioprinting Market Forecast by End User 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 234 Middle East 3D Bioprinting Market Forecast by End User 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 235 Latin America 3D Bioprinting Market Forecast by Component 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 236 Latin America 3D Bioprinting Market Forecast by Component 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 237 Latin America 3D Bioprinting Market Forecast by Component 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 238 Latin America 3D Bioprinting Market Forecast by Component 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 239 Latin America 3D Bioprinting Market Forecast by Component 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 240 Latin America 3D Bioprinting Market Forecast by Application 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 241 Latin America 3D Bioprinting Market Forecast by Application 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 242 Latin America 3D Bioprinting Market Forecast by Application 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 243 Latin America 3D Bioprinting Market Forecast by Application 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 244 Latin America 3D Bioprinting Market Forecast by Application 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 245 Latin America 3D Bioprinting Market Forecast by Material 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 246 Latin America 3D Bioprinting Market Forecast by Material 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 247 Latin America 3D Bioprinting Market Forecast by Material 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 248 Latin America 3D Bioprinting Market Forecast by Material 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 249 Latin America 3D Bioprinting Market Forecast by Material 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 250 Latin America 3D Bioprinting Market Forecast by End User 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 251 Latin America 3D Bioprinting Market Forecast by End User 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 252 Latin America 3D Bioprinting Market Forecast by End User 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 253 Latin America 3D Bioprinting Market Forecast by End User 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 254 Latin America 3D Bioprinting Market Forecast by End User 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 255 Africa 3D Bioprinting Market Forecast by Component 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 256 Africa 3D Bioprinting Market Forecast by Component 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 257 Africa 3D Bioprinting Market Forecast by Component 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 258 Africa 3D Bioprinting Market Forecast by Component 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 259 Africa 3D Bioprinting Market Forecast by Component 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 260 Africa 3D Bioprinting Market Forecast by Application 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 261 Africa 3D Bioprinting Market Forecast by Application 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 262 Africa 3D Bioprinting Market Forecast by Application 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 263 Africa 3D Bioprinting Market Forecast by Application 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 264 Africa 3D Bioprinting Market Forecast by Application 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 265 Africa 3D Bioprinting Market Forecast by Material 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 266 Africa 3D Bioprinting Market Forecast by Material 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 267 Africa 3D Bioprinting Market Forecast by Material 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 268 Africa 3D Bioprinting Market Forecast by Material 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 269 Africa 3D Bioprinting Market Forecast by Material 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 270 Africa 3D Bioprinting Market Forecast by End User 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 271 Africa 3D Bioprinting Market Forecast by End User 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 272 Africa 3D Bioprinting Market Forecast by End User 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 273 Africa 3D Bioprinting Market Forecast by End User 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 274 Africa 3D Bioprinting Market Forecast by End User 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
1.1. Introduction
1.2. Why You Should Read This Report
1.3. Key Questions Answered by This Analytical Report
1.4. Who is This Report For?
1.5. Methodology
1.6. Frequently Asked Questions (FAQ)
1.7. Associated Visiongain Reports
1.8. About Visiongain
2. Introduction to the 3D Bioprinting Market
2.1. 3D Bioprinting Market Definition
2.2. Component Submarkets Definitions
2.3. Application Submarkets Definitions
2.4. Material Submarkets Definitions
2.5. End-User Submarkets Definitions
3. 3D Bioprinting Market Overview
3.1. Global 3D Bioprinting Market Size and Forecast by Region
3.2. Global 3D Bioprinting Market Share by Region
3.3. Market Dynamics
3.3.1. Market Drivers
3.3.1.1. Increasing Use of 3D Bioprinting in the Pharmaceutical and Cosmetology Industries
3.3.1.2. Rising Public and Private Funding to Support Bioprinting Research Activities
3.3.1.3. Technological Advancements in the 3D Bioprinting Industry
3.3.2. Market Restraints/Challenges
3.3.2.1. A dearth of Skilled Professionals
3.3.2.2. High Development & Production Costs
3.3.2.3. Lack of Regulatory Guidelines Governing 3D Bioprinting
3.3.2.4. Socio-ethical Concerns Related to the Use of 3D Bioprinted Products
3.3.2.5. High Cost of 3D Bioprinting
3.3.2.6. Process Control & Understanding
3.3.3. Opportunities
3.3.3.1. Rising Demand for Organ Transplants
3.3.3.2. Growing Awareness of 3D Bioprinting
3.3.3.3. Growing Demand for Regenerative Medicine & Stem Cell Research
3.3.4. Global 3D Bioprinting Market: Trends
3.3.4.1. Research Focuses on Developing High-End 3D Bioprinting Ink
3.3.5. SWOT Analysis
3.3.5.1. Strengths
3.3.5.2. Weaknesses
3.3.5.3. Opportunities
3.3.5.4. Threats
3.3.6. Porter’s Five Forces Analysis
3.3.6.1. Competitive Rivalry
3.3.6.2. Supplier Power
3.3.6.3. Buyer Power
3.3.6.4. Threat of Substitution
3.3.6.5. The threat of New Entry
4. Global 3D Bioprinting Market Analysis and Forecast 2021-2031, by Component (Pre COVID and V, U, W, and L COVID Recovery Scenarios)
4.1. Market Overview
4.1.1. 3D Bioprinters
4.1.1.1. Microextrusion bioprinting
4.1.1.2. Inkjet 3D Bioprinting
4.1.1.3. Laser-assisted Bioprinting
4.1.1.4. Magnetic 3D Bioprinting
4.1.1.5. Other technologies
4.1.2. Bioinks
4.1.2.1. Natural Bioinks
4.1.2.2. Hybrid Bioinks
4.1.2.3. Synthetic Bioinks
5. Global 3D Bioprinting Market Analysis and Forecast, 2021-2031 by Application (Pre COVID and V, U, W, and L COVID Recovery Scenarios)
5.1. Market Overview
5.1.1. Research Applications
5.1.1.1. Drug Research
5.1.1.2. Regenerative Medicine
5.1.1.3. 3D Cell Culture
5.1.2. Clinical Application
5.1.2.1. Skin
5.1.2.2. Bone & Cartilage
5.1.2.3. Blood Vessels
5.1.2.4. Other Clinical Applications
6. Global 3D Bioprinting Market Analysis and Forecast, 2021-2031 by Material (Pre COVID and V, U, W, and L COVID Recovery Scenarios)
6.1. Market Overview
6.1.1. Living Cells
6.1.2. Hydrogels
6.1.3. Extracellular Matrices
6.1.4. Other Biomaterials
7. Global 3D Bioprinting Market Analysis and Forecast, 2021-2031 by End User (Pre COVID and V, U, W, and L COVID Recovery Scenarios)
7.1. Market Overview
7.1.1. Research Organization & Academic Institutes
7.1.2. Biopharmaceuticals Companies
7.1.3. Hospital
8. North America 3D Bioprinting Market Analysis and Forecast, 2021-2031 Pre COVID and V, U, W, and L COVID Recovery Scenarios)
8.1. Market Overview
8.2. North America 3D Bioprinting Market Size and Forecast by Component
8.3. North America 3D Bioprinting Market Size and Forecast by Application
8.4. North America 3D Bioprinting Market Size and Forecast by Material
8.5. North America 3D Bioprinting Market Size and Forecast by End User
8.6. U.S. 3D Bioprinting Market
8.7. Canada 3D Bioprinting Market
9. Europe 3D Bioprinting Market Analysis and Forecast, 2021-2031 (Pre COVID and V, U, W, and L COVID Recovery Scenarios)
9.1. Market Overview
9.2. Europe 3D Bioprinting Market Size and Forecast by Component
9.3. Europe 3D Bioprinting Market Size and Forecast by Application
9.4. Europe 3D Bioprinting Market Size and Forecast by Material
9.5. Europe 3D Bioprinting Market Size and Forecast by End User
9.6. UK 3D Bioprinting Market
9.7. Germany 3D Bioprinting Market
9.8. France 3D Bioprinting Market
9.9. Rest of Europe 3D Bioprinting Market
10. Asia Pacific 3D Bioprinting Market Analysis and Forecast, 2021-2031 (Pre COVID and V, U, W, and L COVID Recovery Scenarios)
10.1. Market Overview
10.2. Asia Pacific 3D Bioprinting Market Size and Forecast by Component
10.3. Asia Pacific 3D Bioprinting Market Size and Forecast by Application
10.4. Asia Pacific 3D Bioprinting Market Size and Forecast by Material
10.5. Asia Pacific 3D Bioprinting Market Size and Forecast by End User
10.6. China 3D Bioprinting Market
10.7. India 3D Bioprinting Market
10.8. Japan 3D Bioprinting Market
10.9. Rest of Asia Pacific 3D Bioprinting Market
11. Latin America 3D Bioprinting Market Analysis and Forecast, 2021-2031 (Pre COVID and V, U, W, and L COVID Recovery Scenarios)
11.1. Market Overview
11.2. Latin America 3D Bioprinting Market Size and Forecast by Component
11.3. Latin America 3D Bioprinting Market Size and Forecast by Application
11.4. Latin America 3D Bioprinting Market Size and Forecast by Material
11.5. Latin America 3D Bioprinting Market Size and Forecast by End User
11.5.1. Brazil 3D Bioprinting Market
11.5.2. Mexico 3D Bioprinting Market
11.5.3. Rest of Latin America 3D Bioprinting Market
12. MEA 3D Bioprinting Market Analysis and Forecast, 2021-2031 (Pre COVID and V, U, W, and L COVID Recovery Scenarios)
12.1. Market Overview
12.2. MEA 3D Bioprinting Market Size and Forecast by Component
12.3. MEA 3D Bioprinting Market Size and Forecast by Application
12.4. MEA 3D Bioprinting Market Size and Forecast by Material
12.5. MEA 3D Bioprinting Market Size and Forecast by End User
12.6. GCC 3D Bioprinting Market
12.7. South Africa 3D Bioprinting Market
12.8. Rest of MEA 3D Bioprinting Market
13. Companies in the 3D Bioprinting Market
13.1. Organovo Holdings, Inc.
13.1.1. Company Snapshot
13.1.2. Company Overview
13.1.3. Financial Performance (2015-2019)
13.1.3.1. Net Revenue
13.1.3.2. Gross Profit
13.1.3.3. Geographical Revenue, 2019
13.1.4. Product Offerings
13.1.5. Recent Initiatives (2017-2019)
13.2. CELLINK
13.2.1. Company Snapshot
13.2.2. Company Overview
13.2.3. Financial Performance (2015-2019)
13.2.3.1. Net Revenue
13.2.3.2. Gross Profit
13.2.3.3. Geographical Revenue, 2019
13.2.4. Product Offerings
13.2.5. Recent Initiatives (2017-2019)
13.3. Allevi Inc.
13.3.1. Company Snapshot
13.3.2. Company Overview
13.3.3. Financial Performance (2015-2019)
13.3.3.1. Net Revenue
13.3.3.2. Gross Profit
13.3.3.3. Geographical Revenue, 2019
13.3.4. Product Offerings
13.3.5. Recent Initiatives (2017-2019)
13.4. Aspect Biosystems Ltd.
13.4.1. Company Snapshot
13.4.2. Company Overview
13.4.3. Financial Performance (2015-2019)
13.4.3.1. Net Revenue
13.4.3.2. Gross Profit
13.4.3.3. Geographical Revenue, 2019
13.4.4. Product Offerings
13.4.5. Recent Initiatives (2017-2019)
13.5. EnvisionTEC GmbH
13.5.1. Company Snapshot
13.5.2. Company Overview
13.5.3. Financial Performance (2015-2019)
13.5.3.1. Net Revenue
13.5.3.2. Gross Profit
13.5.3.3. Geographical Revenue, 2019
13.5.4. Product Offerings
13.5.5. Recent Initiatives (2017-2019)
13.6. Cyfuse Biomedical K.K.
13.6.1. Company Snapshot
13.6.2. Company Overview
13.6.3. Financial Performance (2015-2019)
13.6.3.1. Net Revenue
13.6.3.2. Gross Profit
13.6.3.3. Geographical Revenue, 2019
13.6.4. Product Offerings
13.6.5. Recent Initiatives (2017-2019)
13.7. Poietis
13.7.1. Company Snapshot
13.7.2. Company Overview
13.7.3. Financial Performance (2015-2019)
13.7.3.1. Net Revenue
13.7.3.2. Gross Profit
13.7.3.3. Geographical Revenue, 2019
13.7.4. Product Offerings
13.7.5. Recent Initiatives (2017-2019)
13.8. TeVido BioComponents
13.8.1. Company Snapshot
13.8.2. Company Overview
13.8.3. Financial Performance (2015-2019)
13.8.3.1. Net Revenue
13.8.3.2. Gross Profit
13.8.3.3. Geographical Revenue, 2019
13.8.4. Product Offerings
13.8.5. Recent Initiatives (2017-2019)
13.9. Nano3D Biosciences, Inc.
13.9.1. Company Snapshot
13.9.2. Company Overview
13.9.3. Financial Performance (2015-2019)
13.9.3.1. Net Revenue
13.9.3.2. Gross Profit
13.9.3.3. Geographical Revenue, 2019
13.9.4. Product Offerings
13.9.5. Recent Initiatives (2017-2019)
13.10. ROKIT Healthcare
13.10.1. Company Snapshot
13.10.2. Company Overview
13.10.3. Financial Performance (2015-2019)
13.10.3.1. Net Revenue
13.10.3.2. Gross Profit
13.10.3.3. Geographical Revenue, 2019
13.10.4. Product Offerings
13.10.5. Recent Initiatives (2017-2019)
13.11. Other Notable Players
14. Conclusion
15. Glossary
Associated Visiongain Reports
Visiongain Report Sales Order Form
Appendix A
About Visiongain
Appendix B
Visiongain report evaluation form
LIST OF TABLES
Table 1 3D Bioprinting Market Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Table 2 3D Bioprinting Market Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Table 3 3D Bioprinting Market Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Table 4 3D Bioprinting Market Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Table 5 3D Bioprinting Market Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Table 6 3D Bioprinting Market Drivers & Restraints 2020
Table 7 3D Bioprinting Submarket Forecast by Component 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 8 3D Bioprinting Submarket Forecast by Component 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 9 3D Bioprinting Submarket Forecast by Component 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 10 3D Bioprinting Submarket Forecast by Component 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 11 3D Bioprinting Submarket Forecast by Component 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 12 3D Bioprinters Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) before COVID)
Table 13 3D Bioprinters Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Table 14 3D Bioprinters Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Table 15 3D Bioprinters Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Table 16 3D Bioprinters Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Table 17 Bioinks Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Table 18 Bioinks Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Table 19 Bioinks Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Table 20 Bioinks Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Table 21 Bioinks Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Table 22 3D Bioprinting Submarket Forecast by Application 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 23 3D Bioprinting Submarket Forecast by Application 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 24 3D Bioprinting Submarket Forecast by Application 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 25 3D Bioprinting Submarket Forecast by Application 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 26 3D Bioprinting Submarket Forecast by Application 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 27 Research Applications Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Table 28 Research Applications Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Table 29 Research Applications Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Table 30 Research Applications Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Table 31 Research Applications Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Table 32 Clinical Application Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) Before COVID)
Table 33 Clinical Application Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Table 34 Clinical Application Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Table 35 Clinical Application Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Table 36 Clinical Application Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Table 37 3D Bioprinting Market Forecast by Material 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Table 38 3D Bioprinting Market Forecast by Material 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Table 39 3D Bioprinting Market Forecast by Material 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Table 40 3D Bioprinting Market Forecast by Material 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Table 41 3D Bioprinting Market Forecast by Material 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Table 42 Living Cells Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Table 43 Living Cells Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Table 44 Living Cells Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Table 45 Living Cells Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Table 46 Living Cells Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Table 47 Hydrogels Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Table 48 Hydrogels Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Table 49 Hydrogels Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Table 50 Hydrogels Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Table 51 Hydrogels Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Table 52 Extracellular Matrices Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Table 53 Extracellular Matrices Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Table 54 Extracellular Matrices Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Table 55 Extracellular Matrices Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Table 56 Extracellular Matrices Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Table 57 Other Biomaterials Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Table 58 Other Biomaterials Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Table 59 Other Biomaterials Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Table 60 Other Biomaterials Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Table 61 Other Biomaterials Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Table 62 3D Bioprinting Market Forecast by End User 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Table 63 3D Bioprinting Market Forecast by End User 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Table 64 3D Bioprinting Market Forecast by End User 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Table 65 3D Bioprinting Market Forecast by End User 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Table 66 3D Bioprinting Market Forecast by End User 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Table 67 Research Organization & Academic Institutes Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Table 68 Research Organization & Academic Institutes Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Table 69 Research Organization & Academic Institutes Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Table 70 Research Organization & Academic Institutes Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Table 71 Research Organization & Academic Institutes Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Table 72 Biopharmaceuticals Companies Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Table 73 Biopharmaceuticals Companies Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Table 74 Biopharmaceuticals Companies Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Table 75 Biopharmaceuticals Companies Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Table 76 Biopharmaceuticals Companies Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Table 77 Hospital Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Table 78 Hospital Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Table 79 Hospital Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Table 80 Hospital Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Table 81 Hospital Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Table 82 Regional 3D Bioprinting Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 83 Regional 3D Bioprinting Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 84 Regional 3D Bioprinting Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 85 Regional 3D Bioprinting Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 86 Regional 3D Bioprinting Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 87 North America 3D Bioprinting Market Forecast by Component 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 88 North America 3D Bioprinting Market Forecast by Component 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 89 North America 3D Bioprinting Market Forecast by Component 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 90 North America 3D Bioprinting Market Forecast by Component 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 91 North America 3D Bioprinting Market Forecast by Component 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 92 North America 3D Bioprinting Market Forecast by Application 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 93 North America 3D Bioprinting Market Forecast by Application 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 94 North America 3D Bioprinting Market Forecast by Application 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 95 North America 3D Bioprinting Market Forecast by Application 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 96 North America 3D Bioprinting Market Forecast by Application 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 97 North America 3D Bioprinting Market Forecast by Material 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 98 North America 3D Bioprinting Market Forecast by Material 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 99 North America 3D Bioprinting Market Forecast by Material 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 100 North America 3D Bioprinting Market Forecast by Material 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 101 North America 3D Bioprinting Market Forecast by Material 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 102 North America 3D Bioprinting Market Forecast by End User 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 103 North America 3D Bioprinting Market Forecast by End User 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 104 North America 3D Bioprinting Market Forecast by End User 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 105 North America 3D Bioprinting Market Forecast by End User 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 106 North America 3D Bioprinting Market Forecast by End User 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 107 North America 3D Bioprinting Market Forecast by Country 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 108 North America 3D Bioprinting Market Forecast by Country 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 109 North America 3D Bioprinting Market Forecast by Country 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 110 North America 3D Bioprinting Market Forecast by Country 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 111 North America 3D Bioprinting Market Forecast by Country 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 112 US 3D Bioprinting Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 113 US 3D Bioprinting Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 114 US 3D Bioprinting Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 115 US 3D Bioprinting Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 116 US 3D Bioprinting Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 117 Canada 3D Bioprinting Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 118 Canada 3D Bioprinting Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 119 Canada 3D Bioprinting Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 120 Canada 3D Bioprinting Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 121 Canada 3D Bioprinting Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 122 Europe 3D Bioprinting Market Forecast by Component 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 123 Europe 3D Bioprinting Market Forecast by Component 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 124 Europe 3D Bioprinting Market Forecast by Component 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 125 Europe 3D Bioprinting Market Forecast by Component 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 126 Europe 3D Bioprinting Market Forecast by Component 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 127 Europe 3D Bioprinting Market Forecast by Application 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 128 Europe 3D Bioprinting Market Forecast by Application 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 129 Europe 3D Bioprinting Market Forecast by Application 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 130 Europe 3D Bioprinting Market Forecast by Application 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 131 Europe 3D Bioprinting Market Forecast by Application 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 132 Europe 3D Bioprinting Market Forecast by Material 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 133 Europe 3D Bioprinting Market Forecast by Material 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 134 Europe 3D Bioprinting Market Forecast by Material 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 135 Europe 3D Bioprinting Market Forecast by Material 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 136 Europe 3D Bioprinting Market Forecast by Material 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 137 Europe 3D Bioprinting Market Forecast by End User 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 138 Europe 3D Bioprinting Market Forecast by End User 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 139 Europe 3D Bioprinting Market Forecast by End User 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 140 Europe 3D Bioprinting Market Forecast by End User 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 141 Europe 3D Bioprinting Market Forecast by End User 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 142 Europe 3D Bioprinting Market Forecast by Country 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 143 Europe 3D Bioprinting Market Forecast by Country 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 144 Europe 3D Bioprinting Market Forecast by Country 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 145 Europe 3D Bioprinting Market Forecast by Country 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 146 Europe 3D Bioprinting Market Forecast by Country 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 147 UK 3D Bioprinting Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 148 UK 3D Bioprinting Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 149 UK 3D Bioprinting Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 150 UK 3D Bioprinting Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 151 UK 3D Bioprinting Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 152 Germany 3D Bioprinting Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 153 Germany 3D Bioprinting Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 154 Germany 3D Bioprinting Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 155 Germany 3D Bioprinting Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 156 Germany 3D Bioprinting Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 157 France 3D Bioprinting Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 158 France 3D Bioprinting Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 159 France 3D Bioprinting Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 160 France 3D Bioprinting Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 161 France 3D Bioprinting Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 162 Rest of Europe 3D Bioprinting Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 163 Rest of Europe 3D Bioprinting Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 164 Rest of Europe 3D Bioprinting Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 165 Rest of Europe 3D Bioprinting Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 166 Rest of Europe 3D Bioprinting Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 167 Asia Pacific 3D Bioprinting Market Forecast by Component 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 168 Asia Pacific 3D Bioprinting Market Forecast by Component 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 169 Asia Pacific 3D Bioprinting Market Forecast by Component 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 170 Asia Pacific 3D Bioprinting Market Forecast by Component 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 171 Asia Pacific 3D Bioprinting Market Forecast by Component 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 172 Asia Pacific 3D Bioprinting Market Forecast by Application 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 173 Asia Pacific 3D Bioprinting Market Forecast by Application 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 174 Asia Pacific 3D Bioprinting Market Forecast by Application 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 175 Asia Pacific 3D Bioprinting Market Forecast by Application 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 176 Asia Pacific 3D Bioprinting Market Forecast by Application 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 177 Asia Pacific 3D Bioprinting Market Forecast by Material 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 178 Asia Pacific 3D Bioprinting Market Forecast by Material 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 179 Asia Pacific 3D Bioprinting Market Forecast by Material 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 180 Asia Pacific 3D Bioprinting Market Forecast by Material 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 181 Asia Pacific 3D Bioprinting Market Forecast by Material 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 182 Asia Pacific 3D Bioprinting Market Forecast by End User 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 183 Asia Pacific 3D Bioprinting Market Forecast by End User 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 184 Asia Pacific 3D Bioprinting Market Forecast by End User 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 185 Asia Pacific 3D Bioprinting Market Forecast by End User 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 186 Asia Pacific 3D Bioprinting Market Forecast by End User 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 187 Asia Pacific 3D Bioprinting Market Forecast by Country 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 188 Asia Pacific 3D Bioprinting Market Forecast by Country 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 189 Asia Pacific 3D Bioprinting Market Forecast by Country 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 190 Asia Pacific 3D Bioprinting Market Forecast by Country 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 191 Asia Pacific 3D Bioprinting Market Forecast by Country 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 192 China 3D Bioprinting Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 193 China 3D Bioprinting Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 194 China 3D Bioprinting Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 195 China 3D Bioprinting Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 196 China 3D Bioprinting Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 197 India 3D Bioprinting Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 198 India 3D Bioprinting Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 199 India 3D Bioprinting Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 200 India 3D Bioprinting Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 201 India 3D Bioprinting Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 202 Japan 3D Bioprinting Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 203 Japan 3D Bioprinting Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 204 Japan 3D Bioprinting Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 205 Japan 3D Bioprinting Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 206 Japan 3D Bioprinting Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 207 RoAPAC 3D Bioprinting Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 208 RoAPAC 3D Bioprinting Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 209 RoAPAC 3D Bioprinting Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 210 RoAPAC 3D Bioprinting Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 211 RoAPAC 3D Bioprinting Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 212 Middle East 3D Bioprinting Market Forecast by Component 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 213 Middle East 3D Bioprinting Market Forecast by Component 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 214 Middle East 3D Bioprinting Market Forecast by Component 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 215 Middle East 3D Bioprinting Market Forecast by Component 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 216 Middle East 3D Bioprinting Market Forecast by Component 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 217 Middle East 3D Bioprinting Market Forecast by Application 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 218 Middle East 3D Bioprinting Market Forecast by Application 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 219 Middle East 3D Bioprinting Market Forecast by Application 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 220 Middle East 3D Bioprinting Market Forecast by Application 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 221 Middle East 3D Bioprinting Market Forecast by Application 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 222 Middle East 3D Bioprinting Market Forecast by Material 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 223 Middle East 3D Bioprinting Market Forecast by Material 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 224 Middle East 3D Bioprinting Market Forecast by Material 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 225 Middle East 3D Bioprinting Market Forecast by Material 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 226 Middle East 3D Bioprinting Market Forecast by Material 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 227 Middle East 3D Bioprinting Market Forecast by End User 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 228 Middle East 3D Bioprinting Market Forecast by End User 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 229 Middle East 3D Bioprinting Market Forecast by End User 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 230 Middle East 3D Bioprinting Market Forecast by End User 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 231 Middle East 3D Bioprinting Market Forecast by End User 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 232 Latin America 3D Bioprinting Market Forecast by Component 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 233 Latin America 3D Bioprinting Market Forecast by Component 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 234 Latin America 3D Bioprinting Market Forecast by Component 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 235 Latin America 3D Bioprinting Market Forecast by Component 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 236 Latin America 3D Bioprinting Market Forecast by Component 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 237 Latin America 3D Bioprinting Market Forecast by Application 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 238 Latin America 3D Bioprinting Market Forecast by Application 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 239 Latin America 3D Bioprinting Market Forecast by Application 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 240 Latin America 3D Bioprinting Market Forecast by Application 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 241 Latin America 3D Bioprinting Market Forecast by Application 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 242 Latin America 3D Bioprinting Market Forecast by Material 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 243 Latin America 3D Bioprinting Market Forecast by Material 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 244 Latin America 3D Bioprinting Market Forecast by Material 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 245 Latin America 3D Bioprinting Market Forecast by Material 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 246 Latin America 3D Bioprinting Market Forecast by Material 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 247 Latin America 3D Bioprinting Market Forecast by End User 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 248 Latin America 3D Bioprinting Market Forecast by End User 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 249 Latin America 3D Bioprinting Market Forecast by End User 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 250 Latin America 3D Bioprinting Market Forecast by End User 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 251 Latin America 3D Bioprinting Market Forecast by End User 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 252 Africa 3D Bioprinting Market Forecast by Component 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 253 Africa 3D Bioprinting Market Forecast by Component 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 254 Africa 3D Bioprinting Market Forecast by Component 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 255 Africa 3D Bioprinting Market Forecast by Component 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 256 Africa 3D Bioprinting Market Forecast by Component 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 257 Africa 3D Bioprinting Market Forecast by Application 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 258 Africa 3D Bioprinting Market Forecast by Application 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 259 Africa 3D Bioprinting Market Forecast by Application 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 260 Africa 3D Bioprinting Market Forecast by Application 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 261 Africa 3D Bioprinting Market Forecast by Application 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 262 Africa 3D Bioprinting Market Forecast by Material 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 263 Africa 3D Bioprinting Market Forecast by Material 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 264 Africa 3D Bioprinting Market Forecast by Material 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 265 Africa 3D Bioprinting Market Forecast by Material 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 266 Africa 3D Bioprinting Market Forecast by Material 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 267 Africa 3D Bioprinting Market Forecast by End User 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 268 Africa 3D Bioprinting Market Forecast by End User 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 269 Africa 3D Bioprinting Market Forecast by End User 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 270 Africa 3D Bioprinting Market Forecast by End User 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 271 Africa 3D Bioprinting Market Forecast by End User 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 272 Leading 10 3D Bioprinting Companies (Ranking, Company, Latest Total Company Sales US$M*, HQ)
Table 273 Organovo Holdings, Inc. Profile 2019 (CEO, HQ, Founded, Website)
Table 274 Organovo Holdings, Inc. 3D Bioprinting Selected Recent Contracts 2019 (Date, Contract Type, Details)
Table 275 Organovo Holdings, Inc. 3D Bioprinting Product Offering (Segment, Product Offerings)
Table 276 CELLINK Profile 2019 (CEO, HQ, Founded, Website)
Table 277 CELLINK 3D Bioprinting Selected Recent Contracts 2019 (Date, Contract Type, Details)
Table 278 CELLINK 3D Bioprinting Product Offering (Segment, Product Offerings)
Table 279 Allevi Inc. Profile 2019 (CEO, HQ, Founded, Website)
Table 280 Allevi Inc. 3D Bioprinting Selected Recent Contracts 2017-2019 (Date, Contract Type, Details)
Table 281 Allevi Inc. 3D Bioprinting Product Offering (Segment, Product Offerings)
Table 282 Aspect Biosystems Ltd. Profile 2019 (CEO, HQ, Founded, Website)
Table 283 Aspect Biosystems Ltd. 3D Bioprinting Selected Recent Contracts 2015-2019 (Date, Contract Type, Details)
Table 284 Aspect Biosystems Ltd. 3D Bioprinting Product Offering (Segment, Product Offerings)
Table 285 EnvisionTEC GmbH Profile 2019 (CEO, HQ, Founded, Website)
Table 286 EnvisionTEC GmbH 3D Bioprinting Selected Recent Contracts 2015-2019 (Date, Contract Type, Details)
Table 287 EnvisionTEC 3D Bioprinting Product Offering (Segment, Product Offerings)
Table 288 Cyfuse Biomedical K.K. Profile 2019 (CEO, HQ, Founded, Website)
Table 289 Cyfuse Biomedical K.K. 3D Bioprinting Selected Recent Contracts 2015-2019 (Date, Contract Type, Details)
Table 290 Cyfuse Biomedical K.K. 3D Bioprinting Product Offering (Segment, Product Offerings)
Table 291 Poietis Profile 2019 (CEO, HQ, Founded, Website)
Table 292 Poietis 3D Bioprinting Selected Recent Contracts 2015-2019 (Date, Contract Type, Details)
Table 293 Poietis 3D Bioprinting Product Offering (Segment, Product Offerings)
Table 294 TeVido BioComponents Profile 2019 (CEO, HQ, Founded, Website)
Table 295 TeVido BioComponents 3D Bioprinting Selected Recent Contracts 2015-2019 (Date, Contract Type, Details)
Table 296 TeVido BioComponents 3D Bioprinting Product Offering (Segment, Product Offerings)
Table 297 Nano3D Biosciences, Inc. Profile 2019 (CEO, HQ, Founded, Website)
Table 298 Nano3D Biosciences, Inc. 3D Bioprinting Selected Recent Contracts 2015-2019 (Date, Contract Type, Details)
Table 299 Nano3D Biosciences, Inc. 3D Bioprinting Product Offering (Segment, Product Offerings)
Table 300 ROKIT Healthcare Profile 2019 (CEO, HQ, Founded, Website)
Table 301 ROKIT Healthcare 3D Bioprinting Selected Recent Contracts 2015-2019 (Date, Contract Type, Details)
Table 302 ROKIT Healthcare 3D Bioprinting Product Offering (Segment, Product Offerings)
Table 303 Other Companies Involved in the 3D Bioprinting Market 2020 (Company, Location)
LIST OF FIGURES
Figure 1 3D Bioprinting Market Component Overview
Figure 2 3D Bioprinting Market Application Overview
Figure 3 3D Bioprinting Market Material Overview
Figure 4 3D Bioprinting Market End User Overview
Figure 5 3D Bioprinting Market Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Figure 6 3D Bioprinting Market Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Figure 7 3D Bioprinting Market Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Figure 8 3D Bioprinting Market Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Figure 9 3D Bioprinting Market Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Figure 10 3D Bioprinting Submarket Forecast by Component 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 11 3D Bioprinting Submarket Forecast by Component 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 12 3D Bioprinting Submarket Forecast by Component 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 13 3D Bioprinting Submarket Forecast by Component 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 14 3D Bioprinting Submarket Forecast by Component 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 15 3D Bioprinters Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Figure 16 3D Bioprinters Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Figure 17 3D Bioprinters Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Figure 18 3D Bioprinters Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Figure 19 3D Bioprinters Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Figure 20 Bioinks Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Figure 21 Bioinks Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Figure 22 Bioinks Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Figure 23 Bioinks Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Figure 24 Bioinks Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Figure 25 3D Bioprinting Submarket Forecast by Application 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 26 3D Bioprinting Submarket Forecast by Application 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 27 3D Bioprinting Submarket Forecast by Application 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 28 3D Bioprinting Submarket Forecast by Application 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 29 3D Bioprinting Submarket Forecast by Application 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 30 Research Applications Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Figure 31 Research Applications Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Figure 32 Research Applications Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Figure 33 Research Applications Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Figure 34 Research Applications Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Figure 35 Clinical Application Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Figure 36 Clinical Application Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Figure 37 Clinical Application Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Figure 38 Clinical Application Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Figure 39 Clinical Application Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Figure 40 3D Bioprinting Market Forecast by Material 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Figure 41 3D Bioprinting Market Forecast by Material 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Figure 42 3D Bioprinting Market Forecast by Material 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Figure 43 3D Bioprinting Market Forecast by Material 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Figure 44 3D Bioprinting Market Forecast by Material 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Figure 45 Living Cells Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Figure 46 Living Cells Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Figure 47 Living Cells Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Figure 48 Living Cells Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Figure 49 Living Cells Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Figure 50 Hydrogels Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Figure 51 Hydrogels Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Figure 52 Hydrogels Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Figure 53 Hydrogels Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Figure 54 Hydrogels Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Figure 55 Extracellular Matrices Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Figure 56 Extracellular Matrices Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Figure 57 Extracellular Matrices Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Figure 58 Extracellular Matrices Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Figure 59 Extracellular Matrices Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Figure 60 Other Biomaterials Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Figure 61 Other Biomaterials Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Figure 62 Other Biomaterials Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Figure 63 Other Biomaterials Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Figure 64 Other Biomaterials Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Figure 65 3D Bioprinting Market Forecast by End User 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Figure 66 3D Bioprinting Market Forecast by End User 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Figure 67 3D Bioprinting Market Forecast by End User 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Figure 68 3D Bioprinting Market Forecast by End User 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Figure 69 3D Bioprinting Market Forecast by End User 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Figure 70 Research Organization & Academic Institutes Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Figure 71 Research Organization & Academic Institutes Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Figure 72 Research Organization & Academic Institutes Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Figure 73 Research Organization & Academic Institutes Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Figure 74 Research Organization & Academic Institutes Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Figure 75 Biopharmaceuticals Companies Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Figure 76 Biopharmaceuticals Companies Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Figure 77 Biopharmaceuticals Companies Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Figure 78 Biopharmaceuticals Companies Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Figure 79 Biopharmaceuticals Companies Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Figure 80 Hospital Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Figure 81 Hospital Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Figure 82 Hospital Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Figure 83 Hospital Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Figure 84 Hospital Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Figure 85 Regional 3D Bioprinting Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 86 Regional 3D Bioprinting Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 87 Regional 3D Bioprinting Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 88 Regional 3D Bioprinting Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 89 Regional 3D Bioprinting Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 90 North America 3D Bioprinting Market Forecast by Component 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 91 North America 3D Bioprinting Market Forecast by Component 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 92 North America 3D Bioprinting Market Forecast by Component 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 93 North America 3D Bioprinting Market Forecast by Component 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 94 North America 3D Bioprinting Market Forecast by Component 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 95 North America 3D Bioprinting Market Forecast by Application 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 96 North America 3D Bioprinting Market Forecast by Application 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 97 North America 3D Bioprinting Market Forecast by Application 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 98 North America 3D Bioprinting Market Forecast by Application 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 99 North America 3D Bioprinting Market Forecast by Application 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 100 North America 3D Bioprinting Market Forecast by Material 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 101 North America 3D Bioprinting Market Forecast by Material 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 102 North America 3D Bioprinting Market Forecast by Material 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 103 North America 3D Bioprinting Market Forecast by Material 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 104 North America 3D Bioprinting Market Forecast by Material 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 105 North America 3D Bioprinting Market Forecast by End User 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 106 North America 3D Bioprinting Market Forecast by End User 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 107 North America 3D Bioprinting Market Forecast by End User 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 108 North America 3D Bioprinting Market Forecast by End User 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 109 North America 3D Bioprinting Market Forecast by End User 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 110 North America 3D Bioprinting Market Forecast by Country 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 111 North America 3D Bioprinting Market Forecast by Country 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 112 North America 3D Bioprinting Market Forecast by Country 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 113 North America 3D Bioprinting Market Forecast by Country 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 114 North America 3D Bioprinting Market Forecast by Country 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 115 US 3D Bioprinting Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 116 US 3D Bioprinting Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 117 US 3D Bioprinting Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 118 US 3D Bioprinting Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 119 US 3D Bioprinting Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 120 Canada 3D Bioprinting Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 121 Canada 3D Bioprinting Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 122 Canada 3D Bioprinting Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 123 Canada 3D Bioprinting Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 124 Canada 3D Bioprinting Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 125 Europe 3D Bioprinting Market Forecast by Component 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 126 Europe 3D Bioprinting Market Forecast by Component 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 127 Europe 3D Bioprinting Market Forecast by Component 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 128 Europe 3D Bioprinting Market Forecast by Component 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 129 Europe 3D Bioprinting Market Forecast by Component 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 130 Europe 3D Bioprinting Market Forecast by Application 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 131 Europe 3D Bioprinting Market Forecast by Application 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 132 Europe 3D Bioprinting Market Forecast by Application 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 133 Europe 3D Bioprinting Market Forecast by Application 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 134 Europe 3D Bioprinting Market Forecast by Application 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 135 Europe 3D Bioprinting Market Forecast by Material 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 136 Europe 3D Bioprinting Market Forecast by Material 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 137 Europe 3D Bioprinting Market Forecast by Material 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 138 Europe 3D Bioprinting Market Forecast by Material 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 139 Europe 3D Bioprinting Market Forecast by Material 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 140 Europe 3D Bioprinting Market Forecast by End User 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 141 Europe 3D Bioprinting Market Forecast by End User 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 142 Europe 3D Bioprinting Market Forecast by End User 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 143 Europe 3D Bioprinting Market Forecast by End User 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 144 Europe 3D Bioprinting Market Forecast by End User 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 145 Europe 3D Bioprinting Market Forecast by Country 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 146 Europe 3D Bioprinting Market Forecast by Country 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 147 Europe 3D Bioprinting Market Forecast by Country 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 148 Europe 3D Bioprinting Market Forecast by Country 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 149 Europe 3D Bioprinting Market Forecast by Country 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 150 UK 3D Bioprinting Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 151 UK 3D Bioprinting Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 152 UK 3D Bioprinting Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 153 UK 3D Bioprinting Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 154 UK 3D Bioprinting Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 155 Germany 3D Bioprinting Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 156 Germany 3D Bioprinting Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 157 Germany 3D Bioprinting Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 158 Germany 3D Bioprinting Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 159 Germany 3D Bioprinting Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 160 France 3D Bioprinting Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 161 France 3D Bioprinting Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 162 France 3D Bioprinting Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 163 France 3D Bioprinting Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 164 France 3D Bioprinting Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 165 Rest of Europe 3D Bioprinting Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 166 Rest of Europe 3D Bioprinting Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 167 Rest of Europe 3D Bioprinting Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 168 Rest of Europe 3D Bioprinting Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 169 Rest of Europe 3D Bioprinting Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 170 Asia Pacific 3D Bioprinting Market Forecast by Component 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 171 Asia Pacific 3D Bioprinting Market Forecast by Component 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 172 Asia Pacific 3D Bioprinting Market Forecast by Component 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 173 Asia Pacific 3D Bioprinting Market Forecast by Component 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 174 Asia Pacific 3D Bioprinting Market Forecast by Component 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 175 Asia Pacific 3D Bioprinting Market Forecast by Application 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 176 Asia Pacific 3D Bioprinting Market Forecast by Application 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 177 Asia Pacific 3D Bioprinting Market Forecast by Application 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 178 Asia Pacific 3D Bioprinting Market Forecast by Application 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 179 Asia Pacific 3D Bioprinting Market Forecast by Application 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 180 Asia Pacific 3D Bioprinting Market Forecast by Material 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 181 Asia Pacific 3D Bioprinting Market Forecast by Material 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 182 Asia Pacific 3D Bioprinting Market Forecast by Material 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 183 Asia Pacific 3D Bioprinting Market Forecast by Material 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 184 Asia Pacific 3D Bioprinting Market Forecast by Material 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 185 Asia Pacific 3D Bioprinting Market Forecast by End User 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 186 Asia Pacific 3D Bioprinting Market Forecast by End User 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 187 Asia Pacific 3D Bioprinting Market Forecast by End User 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 188 Asia Pacific 3D Bioprinting Market Forecast by End User 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 189 Asia Pacific 3D Bioprinting Market Forecast by End User 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 190 Asia Pacific 3D Bioprinting Market Forecast by Country 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 191 Asia Pacific 3D Bioprinting Market Forecast by Country 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 192 Asia Pacific 3D Bioprinting Market Forecast by Country 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 193 Asia Pacific 3D Bioprinting Market Forecast by Country 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 194 Asia Pacific 3D Bioprinting Market Forecast by Country 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 195 China 3D Bioprinting Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 196 China 3D Bioprinting Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 197 China 3D Bioprinting Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 198 China 3D Bioprinting Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 199 China 3D Bioprinting Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 200 India 3D Bioprinting Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 201 India 3D Bioprinting Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 202 India 3D Bioprinting Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 203 India 3D Bioprinting Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 204 India 3D Bioprinting Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 205 Japan 3D Bioprinting Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 206 Japan 3D Bioprinting Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 207 Japan 3D Bioprinting Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 208 Japan 3D Bioprinting Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 209 Japan 3D Bioprinting Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 210 RoAPAC 3D Bioprinting Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 211 RoAPAC 3D Bioprinting Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 212 RoAPAC 3D Bioprinting Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 213 RoAPAC 3D Bioprinting Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 214 RoAPAC 3D Bioprinting Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 215 Middle East 3D Bioprinting Market Forecast by Component 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 216 Middle East 3D Bioprinting Market Forecast by Component 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 217 Middle East 3D Bioprinting Market Forecast by Component 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 218 Middle East 3D Bioprinting Market Forecast by Component 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 219 Middle East 3D Bioprinting Market Forecast by Component 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 220 Middle East 3D Bioprinting Market Forecast by Application 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 221 Middle East 3D Bioprinting Market Forecast by Application 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 222 Middle East 3D Bioprinting Market Forecast by Application 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 223 Middle East 3D Bioprinting Market Forecast by Application 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 224 Middle East 3D Bioprinting Market Forecast by Application 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 225 Middle East 3D Bioprinting Market Forecast by Material 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 226 Middle East 3D Bioprinting Market Forecast by Material 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 227 Middle East 3D Bioprinting Market Forecast by Material 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 228 Middle East 3D Bioprinting Market Forecast by Material 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 229 Middle East 3D Bioprinting Market Forecast by Material 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 230 Middle East 3D Bioprinting Market Forecast by End User 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 231 Middle East 3D Bioprinting Market Forecast by End User 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 232 Middle East 3D Bioprinting Market Forecast by End User 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 233 Middle East 3D Bioprinting Market Forecast by End User 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 234 Middle East 3D Bioprinting Market Forecast by End User 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 235 Latin America 3D Bioprinting Market Forecast by Component 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 236 Latin America 3D Bioprinting Market Forecast by Component 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 237 Latin America 3D Bioprinting Market Forecast by Component 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 238 Latin America 3D Bioprinting Market Forecast by Component 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 239 Latin America 3D Bioprinting Market Forecast by Component 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 240 Latin America 3D Bioprinting Market Forecast by Application 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 241 Latin America 3D Bioprinting Market Forecast by Application 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 242 Latin America 3D Bioprinting Market Forecast by Application 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 243 Latin America 3D Bioprinting Market Forecast by Application 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 244 Latin America 3D Bioprinting Market Forecast by Application 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 245 Latin America 3D Bioprinting Market Forecast by Material 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 246 Latin America 3D Bioprinting Market Forecast by Material 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 247 Latin America 3D Bioprinting Market Forecast by Material 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 248 Latin America 3D Bioprinting Market Forecast by Material 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 249 Latin America 3D Bioprinting Market Forecast by Material 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 250 Latin America 3D Bioprinting Market Forecast by End User 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 251 Latin America 3D Bioprinting Market Forecast by End User 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 252 Latin America 3D Bioprinting Market Forecast by End User 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 253 Latin America 3D Bioprinting Market Forecast by End User 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 254 Latin America 3D Bioprinting Market Forecast by End User 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 255 Africa 3D Bioprinting Market Forecast by Component 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 256 Africa 3D Bioprinting Market Forecast by Component 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 257 Africa 3D Bioprinting Market Forecast by Component 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 258 Africa 3D Bioprinting Market Forecast by Component 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 259 Africa 3D Bioprinting Market Forecast by Component 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 260 Africa 3D Bioprinting Market Forecast by Application 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 261 Africa 3D Bioprinting Market Forecast by Application 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 262 Africa 3D Bioprinting Market Forecast by Application 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 263 Africa 3D Bioprinting Market Forecast by Application 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 264 Africa 3D Bioprinting Market Forecast by Application 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 265 Africa 3D Bioprinting Market Forecast by Material 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 266 Africa 3D Bioprinting Market Forecast by Material 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 267 Africa 3D Bioprinting Market Forecast by Material 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 268 Africa 3D Bioprinting Market Forecast by Material 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 269 Africa 3D Bioprinting Market Forecast by Material 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 270 Africa 3D Bioprinting Market Forecast by End User 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 271 Africa 3D Bioprinting Market Forecast by End User 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 272 Africa 3D Bioprinting Market Forecast by End User 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 273 Africa 3D Bioprinting Market Forecast by End User 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 274 Africa 3D Bioprinting Market Forecast by End User 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Companies Profiled in the Report
1. Organovo Holding, Inc.
2. Luxexcel Group B.V.
3. TeVido BioDevices LLC
4. 3Dynamics Systems Ltd.
5. Cyfuse Biomedical K.K.
6. Aspect Biosystems Ltd.
7. Stratasys Ltd.
8. Voxeljet A.G.
9. Bio3D Technologies Pte. Ltd.
10. Materialise N.V.
List of Companies Mentioned in the Report:
1. Envision TEC
2. CELLINK
3. Allevi Inc.
4. Poietis
5. TeVido BioDevices
6. ROKIT Healthcare
7. Digilab, Inc.
8. regenHU
9. GeSiM
10. Advanced Solutions Life Sciences
11. Regenovo Biotechnology Co., Ltd.
12. Life SI
13. Longe Medikal
14. Regemat 3D
15. ROKIT Healthcare
16. FoldInk
17. Next Big Innovation Labs
18. Brinter
19. Kwambio
20. Precise Bio
21. TeVido Biodevices
22. 3D Bioprinting Solutions
23. Nanofiber Solutions
24. Advanced Solutions Life Sciences
25. Pandorum Technologies
26. MedPrin
27. regenHU
28. Medtronic
29. Next Big Innovation Labs
30. SE3D EDUCATION LLC
31. UNIVERSIDAD DEL PAIS
32. Allegro 3D, Inc.
33. University Medical Center
34. MedPrin
35. U. of Minho
36. Morphodyne SA
37. Cellbricks
38. Lynntech, Inc.
39. Aston University
40. Precise Bio Inc.
41. Biolife4D
42. Advanced Biomatrix
43. Nanofiber Solutions
44. Lunds universitet
45. TeVido BioDevices LLC
46. Modern Meadow
47. Prellis Biologics
48. A Lab-On-A-Printer
49. GeSIM
List of Organizations Mentioned in the Report:
1. Asian Manufacturing Association
2. Chinese Food and Drug Administration
3. European Commission
4. European Medicines Agency
5. Food and Drug Administration
6. Harvard University
7. Industry Alliance of China 3D Printing Technology
8. Medicines and Healthcare Regulatory Agency
9. Ministry of Industry and Information technology
10. National Additive Manufacturing Innovation Institute
11. National Institute of Health
12. National Network for Manufacturing Innovation
13. North Carolina State University
14. Technology Strategy Board
15. The Knight Cancer Institute of Oregon Health and Science University
16. University of Central Lancashire
17. Wake Forest Institute for Regenerative Medicine (WFIRM)
18. Walter Reed National Military Medical Centre
19. Weill Cornell Medical College
20. World Health Organisation (WHO)
21. Wyss Institute at Harvard University
1. Organovo Holding, Inc.
2. Luxexcel Group B.V.
3. TeVido BioDevices LLC
4. 3Dynamics Systems Ltd.
5. Cyfuse Biomedical K.K.
6. Aspect Biosystems Ltd.
7. Stratasys Ltd.
8. Voxeljet A.G.
9. Bio3D Technologies Pte. Ltd.
10. Materialise N.V.
List of Companies Mentioned in the Report:
1. Envision TEC
2. CELLINK
3. Allevi Inc.
4. Poietis
5. TeVido BioDevices
6. ROKIT Healthcare
7. Digilab, Inc.
8. regenHU
9. GeSiM
10. Advanced Solutions Life Sciences
11. Regenovo Biotechnology Co., Ltd.
12. Life SI
13. Longe Medikal
14. Regemat 3D
15. ROKIT Healthcare
16. FoldInk
17. Next Big Innovation Labs
18. Brinter
19. Kwambio
20. Precise Bio
21. TeVido Biodevices
22. 3D Bioprinting Solutions
23. Nanofiber Solutions
24. Advanced Solutions Life Sciences
25. Pandorum Technologies
26. MedPrin
27. regenHU
28. Medtronic
29. Next Big Innovation Labs
30. SE3D EDUCATION LLC
31. UNIVERSIDAD DEL PAIS
32. Allegro 3D, Inc.
33. University Medical Center
34. MedPrin
35. U. of Minho
36. Morphodyne SA
37. Cellbricks
38. Lynntech, Inc.
39. Aston University
40. Precise Bio Inc.
41. Biolife4D
42. Advanced Biomatrix
43. Nanofiber Solutions
44. Lunds universitet
45. TeVido BioDevices LLC
46. Modern Meadow
47. Prellis Biologics
48. A Lab-On-A-Printer
49. GeSIM
List of Organizations Mentioned in the Report:
1. Asian Manufacturing Association
2. Chinese Food and Drug Administration
3. European Commission
4. European Medicines Agency
5. Food and Drug Administration
6. Harvard University
7. Industry Alliance of China 3D Printing Technology
8. Medicines and Healthcare Regulatory Agency
9. Ministry of Industry and Information technology
10. National Additive Manufacturing Innovation Institute
11. National Institute of Health
12. National Network for Manufacturing Innovation
13. North Carolina State University
14. Technology Strategy Board
15. The Knight Cancer Institute of Oregon Health and Science University
16. University of Central Lancashire
17. Wake Forest Institute for Regenerative Medicine (WFIRM)
18. Walter Reed National Military Medical Centre
19. Weill Cornell Medical College
20. World Health Organisation (WHO)
21. Wyss Institute at Harvard University
Download sample pages
Complete the form below to download your free sample pages for 3D Bioprinting Market Report to 2031Related reports
3D Printing for Healthcare Market Report 2021-2031
The growing use of this technology in many applications such as transplantation, drug delivery, 3D printed organs, and many others...Full DetailsPublished: 27 July 20213D Radar Market Report 2021-2031
The growth of this market can be attributed to the rising demand for advanced radar systems along with increasing adoption...
Full DetailsPublished: 01 January 19703D Animation Market Report to 2031
The rising adoption of visual effects (VFX) technology in movies, the trend of digital marketing, and growing demand for 3D...Full DetailsPublished: 01 January 19703D Concrete Printing Market Report 2021-2031
With the construction company’s ongoing efforts to bring 3D concrete printing into mainstream construction, it is projected that the global...Full DetailsPublished: 24 November 2020
Download sample pages
Complete the form below to download your free sample pages for 3D Bioprinting Market Report to 2031Do you have any custom requirements we can help you with?
Any specific country, geo region, market segment or specific company information?
Email us today, we can discuss your needs and see how we can help: sara.peerun@visiongain.com
Would you like a free report overview of the report of your choice?
If so, please drop an email to Sara Peerun stating your chosen report title to sara.peerun@visiongain.com
Visiongain’s reports are based on comprehensive primary and secondary research. Those studies provide global market forecasts (sales by drug and class, with sub-markets and leading nations covered) and analyses of market drivers and restraints (including SWOT analysis) and current pipeline developments. To find out more about our reports methodology, please email sara.peerun@visiongain.com
“Thank you for this Gene Therapy R&D Market report and for how easy the process was. Your colleague was very helpful and the report is just right for my purpose. This is the 2nd good report from Visiongain and a good price.”
Dr Luz Chapa Azuella, Mexico
American Association of Colleges of Pharmacy
American College of Clinical Pharmacy
American Pharmacists Association
American Society for Pharmacy Law
American Society of Consultant Pharmacists
American Society of Health-System Pharmacists
Association of Special Pharmaceutical Manufacturers
Australian College of Pharmacy
Biotechnology Industry Organization
Canadian Pharmacists Association
Canadian Society of Hospital Pharmacists
Chinese Pharmaceutical Association
College of Psychiatric and Neurologic Pharmacists
Danish Association of Pharmaconomists
European Association of Employed Community Pharmacists in Europe
European Medicines Agency
Federal Drugs Agency
General Medical Council
Head of Medicines Agency
International Federation of Pharmaceutical Manufacturers & Associations
International Pharmaceutical Federation
International Pharmaceutical Students’ Federation
Medicines and Healthcare Products Regulatory Agency
National Pharmacy Association
Norwegian Pharmacy Association
Ontario Pharmacists Association
Pakistan Pharmacists Association
Pharmaceutical Association of Mauritius
Pharmaceutical Group of the European Union
Pharmaceutical Society of Australia
Pharmaceutical Society of Ireland
Pharmaceutical Society Of New Zealand
Pharmaceutical Society of Northern Ireland
Professional Compounding Centers of America
Royal Pharmaceutical Society
The American Association of Pharmaceutical Scientists
The BioIndustry Association
The Controlled Release Society
The European Federation of Pharmaceutical Industries and Associations
The European Personalised Medicine Association
The Institute of Clinical Research
The International Society for Pharmaceutical Engineering
The Pharmaceutical Association of Israel
The Pharmaceutical Research and Manufacturers of America
The Pharmacy Guild of Australia
The Society of Hospital Pharmacists of Australia
Visiongain Pharma
Visiongain Pharma
Visiongain PharmaLatest Pharma news
Visiongain Publishes Deep Frozen Packaging Logistics Market Report 2023-2033
The global Deep Frozen Packaging Logistics market was valued at US$21,088.3 million in 2022 and is projected to grow at a CAGR of 7.7% during the forecast period 2023-2033.
29 March 2023
Visiongain Publishes Automation in Biopharma Industry Market Report 2023-2033
The global Automation in Biopharma Industry market was valued at US$1,784.1 million in 2022 and is projected to grow at a CAGR of 5.7% during the forecast period 2023-2033.
20 March 2023
Visiongain Publishes eClinical Solutions Market Report 2023-2033
The global eClinical Solutions market was valued at US$8.03 billion in 2022 and is projected to grow at a CAGR of 13.09% during the forecast period 2023-2033.
17 March 2023
Visiongain Publishes Therapeutic Respiratory Devices Market Report 2023-2033
The global Therapeutic Respiratory Devices market was valued at US$59.49 billion in 2022 and is projected to grow at a CAGR of 8.02% during the forecast period 2023-2033.
15 March 2023
